| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| tau Proteins | 41 | 2024 | 2106 | 3.700 |
Why?
|
| Cerebral Amyloid Angiopathy | 43 | 2023 | 887 | 3.630 |
Why?
|
| Alzheimer Disease | 113 | 2025 | 8717 | 3.590 |
Why?
|
| Amyloid beta-Peptides | 74 | 2024 | 3886 | 3.580 |
Why?
|
| Tauopathies | 14 | 2024 | 325 | 2.650 |
Why?
|
| Brain | 129 | 2025 | 27163 | 2.440 |
Why?
|
| Neurofibrillary Tangles | 21 | 2022 | 457 | 1.930 |
Why?
|
| Plaque, Amyloid | 27 | 2022 | 769 | 1.600 |
Why?
|
| Temporal Lobe | 14 | 2018 | 1717 | 1.400 |
Why?
|
| Frontotemporal Lobar Degeneration | 9 | 2022 | 102 | 1.290 |
Why?
|
| Pick Disease of the Brain | 4 | 2024 | 42 | 1.180 |
Why?
|
| Neurons | 44 | 2024 | 9517 | 1.160 |
Why?
|
| Cerebral Hemorrhage | 22 | 2023 | 2655 | 1.140 |
Why?
|
| Presenilin-1 | 15 | 2025 | 665 | 1.060 |
Why?
|
| Proteostasis Deficiencies | 3 | 2020 | 38 | 0.960 |
Why?
|
| Neisseria meningitidis | 10 | 2001 | 111 | 0.950 |
Why?
|
| Neurodegenerative Diseases | 9 | 2024 | 1089 | 0.930 |
Why?
|
| alpha-Synuclein | 14 | 2024 | 773 | 0.920 |
Why?
|
| Induced Pluripotent Stem Cells | 5 | 2024 | 1882 | 0.920 |
Why?
|
| Carbolines | 8 | 2024 | 288 | 0.870 |
Why?
|
| Cerebral Infarction | 8 | 2020 | 968 | 0.840 |
Why?
|
| Autopsy | 18 | 2022 | 1011 | 0.810 |
Why?
|
| Amyloid beta-Protein Precursor | 17 | 2018 | 1117 | 0.800 |
Why?
|
| Headache | 6 | 2024 | 1261 | 0.770 |
Why?
|
| Personality Disorders | 2 | 2024 | 726 | 0.740 |
Why?
|
| Cerebral Cortex | 21 | 2024 | 5754 | 0.730 |
Why?
|
| Fatal Outcome | 16 | 2020 | 1836 | 0.720 |
Why?
|
| Sterilization | 1 | 2021 | 132 | 0.720 |
Why?
|
| Multiple System Atrophy | 4 | 2022 | 132 | 0.710 |
Why?
|
| Peptide Fragments | 18 | 2021 | 5141 | 0.710 |
Why?
|
| Microglia | 13 | 2024 | 1370 | 0.700 |
Why?
|
| Guillain-Barre Syndrome | 1 | 2021 | 128 | 0.660 |
Why?
|
| Lewy Body Disease | 11 | 2019 | 254 | 0.660 |
Why?
|
| Astrocytoma | 2 | 2023 | 773 | 0.660 |
Why?
|
| Magnetic Resonance Imaging | 66 | 2024 | 36582 | 0.660 |
Why?
|
| Frontal Lobe | 6 | 2015 | 1408 | 0.630 |
Why?
|
| Humans | 340 | 2025 | 767040 | 0.620 |
Why?
|
| Mutation | 42 | 2025 | 30211 | 0.600 |
Why?
|
| Brain Neoplasms | 16 | 2024 | 9108 | 0.590 |
Why?
|
| Diagnosis, Differential | 25 | 2024 | 12986 | 0.590 |
Why?
|
| Neurotoxicity Syndromes | 2 | 2021 | 302 | 0.590 |
Why?
|
| Fatigue | 2 | 2024 | 1556 | 0.580 |
Why?
|
| Aged, 80 and over | 93 | 2025 | 59548 | 0.580 |
Why?
|
| Isocitrate Dehydrogenase | 6 | 2024 | 951 | 0.560 |
Why?
|
| Hippocampus | 15 | 2024 | 3777 | 0.550 |
Why?
|
| Entorhinal Cortex | 7 | 2024 | 285 | 0.550 |
Why?
|
| Amyloid | 11 | 2023 | 849 | 0.540 |
Why?
|
| Mice, Transgenic | 41 | 2021 | 9551 | 0.540 |
Why?
|
| Glioma | 9 | 2023 | 3502 | 0.520 |
Why?
|
| Echinococcus | 5 | 2000 | 14 | 0.520 |
Why?
|
| Aphasia, Primary Progressive | 1 | 2017 | 84 | 0.510 |
Why?
|
| Parkinson Disease | 13 | 2022 | 2886 | 0.510 |
Why?
|
| Spinal Cord Neoplasms | 4 | 2023 | 263 | 0.500 |
Why?
|
| Male | 198 | 2025 | 364203 | 0.500 |
Why?
|
| Aged | 133 | 2025 | 171319 | 0.500 |
Why?
|
| Prions | 3 | 2024 | 177 | 0.490 |
Why?
|
| Cognition Disorders | 10 | 2019 | 3968 | 0.490 |
Why?
|
| Adrenoleukodystrophy | 4 | 2023 | 144 | 0.490 |
Why?
|
| Paresis | 3 | 2023 | 177 | 0.480 |
Why?
|
| Synapses | 9 | 2023 | 1759 | 0.470 |
Why?
|
| Myelinolysis, Central Pontine | 1 | 2014 | 17 | 0.470 |
Why?
|
| Tay-Sachs Disease | 1 | 2014 | 20 | 0.460 |
Why?
|
| Female | 186 | 2025 | 396660 | 0.460 |
Why?
|
| Frontotemporal Dementia | 4 | 2025 | 249 | 0.440 |
Why?
|
| Amyotrophic Lateral Sclerosis | 7 | 2025 | 1481 | 0.410 |
Why?
|
| Hydrocephalus, Normal Pressure | 2 | 2024 | 101 | 0.410 |
Why?
|
| Diplopia | 1 | 2014 | 217 | 0.410 |
Why?
|
| Vasculitis, Central Nervous System | 4 | 2016 | 45 | 0.400 |
Why?
|
| Animals | 114 | 2025 | 168965 | 0.390 |
Why?
|
| Helminth Proteins | 3 | 2000 | 173 | 0.390 |
Why?
|
| Autoradiography | 6 | 2019 | 725 | 0.390 |
Why?
|
| Epidermolysis Bullosa | 1 | 2011 | 29 | 0.390 |
Why?
|
| Radiopharmaceuticals | 9 | 2019 | 2702 | 0.390 |
Why?
|
| Pregnancy Trimester, First | 1 | 2016 | 917 | 0.380 |
Why?
|
| Meningococcal Infections | 3 | 2001 | 78 | 0.380 |
Why?
|
| Central Nervous System Diseases | 1 | 2016 | 518 | 0.380 |
Why?
|
| Middle Aged | 107 | 2025 | 223233 | 0.370 |
Why?
|
| Microvessels | 4 | 2021 | 585 | 0.370 |
Why?
|
| Dementia | 10 | 2019 | 2741 | 0.370 |
Why?
|
| Multiple Sclerosis | 2 | 2021 | 3229 | 0.370 |
Why?
|
| Intracranial Arteriosclerosis | 2 | 2019 | 138 | 0.370 |
Why?
|
| Immune Reconstitution Inflammatory Syndrome | 1 | 2011 | 61 | 0.370 |
Why?
|
| Mice | 72 | 2024 | 81912 | 0.360 |
Why?
|
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 | 2014 | 238 | 0.350 |
Why?
|
| Sarcoidosis | 1 | 2016 | 535 | 0.350 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2016 | 2183 | 0.350 |
Why?
|
| Spinal Cord | 9 | 2025 | 1811 | 0.340 |
Why?
|
| Isoquinolines | 2 | 2024 | 349 | 0.340 |
Why?
|
| Intracranial Hemorrhages | 5 | 2019 | 810 | 0.340 |
Why?
|
| Pyramidal Cells | 3 | 2024 | 367 | 0.340 |
Why?
|
| Fusobacterium Infections | 1 | 2010 | 54 | 0.340 |
Why?
|
| DNA-Binding Proteins | 11 | 2024 | 9612 | 0.330 |
Why?
|
| Sex Characteristics | 2 | 2018 | 2647 | 0.330 |
Why?
|
| Vasculitis | 4 | 2007 | 526 | 0.330 |
Why?
|
| Social Adjustment | 1 | 2011 | 634 | 0.320 |
Why?
|
| Astrocytes | 11 | 2023 | 1352 | 0.320 |
Why?
|
| Brain Abscess | 1 | 2010 | 122 | 0.320 |
Why?
|
| Gyrus Cinguli | 2 | 2017 | 1118 | 0.310 |
Why?
|
| Gliosis | 6 | 2011 | 246 | 0.310 |
Why?
|
| Affective Symptoms | 1 | 2011 | 418 | 0.310 |
Why?
|
| Apolipoprotein E4 | 7 | 2020 | 709 | 0.310 |
Why?
|
| Vascular Neoplasms | 1 | 2010 | 167 | 0.300 |
Why?
|
| Apolipoprotein E2 | 3 | 2020 | 134 | 0.300 |
Why?
|
| CADASIL | 1 | 2009 | 83 | 0.300 |
Why?
|
| Glioblastoma | 7 | 2024 | 3461 | 0.300 |
Why?
|
| Spinocerebellar Ataxias | 2 | 2024 | 108 | 0.300 |
Why?
|
| Sialic Acids | 7 | 2001 | 122 | 0.300 |
Why?
|
| Telangiectasia, Hereditary Hemorrhagic | 1 | 2010 | 141 | 0.300 |
Why?
|
| Lewy Bodies | 4 | 2024 | 141 | 0.300 |
Why?
|
| Subacute Sclerosing Panencephalitis | 1 | 2007 | 26 | 0.290 |
Why?
|
| Phosphorylation | 13 | 2024 | 8310 | 0.290 |
Why?
|
| Staining and Labeling | 6 | 2020 | 1076 | 0.290 |
Why?
|
| Positron-Emission Tomography | 16 | 2024 | 6550 | 0.290 |
Why?
|
| Encephalitis | 4 | 2021 | 441 | 0.280 |
Why?
|
| Leukoencephalopathy, Progressive Multifocal | 2 | 2008 | 133 | 0.280 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 7 | 2017 | 1655 | 0.280 |
Why?
|
| Skin Diseases, Papulosquamous | 1 | 2006 | 17 | 0.280 |
Why?
|
| Arteriovenous Malformations | 1 | 2010 | 396 | 0.280 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 2 | 2015 | 265 | 0.270 |
Why?
|
| Nerve Tissue Proteins | 13 | 2022 | 4401 | 0.270 |
Why?
|
| Age of Onset | 8 | 2025 | 3344 | 0.270 |
Why?
|
| Antibodies | 3 | 2018 | 2419 | 0.260 |
Why?
|
| Antibodies, Monoclonal | 11 | 2018 | 9245 | 0.260 |
Why?
|
| Metagenomics | 2 | 2021 | 473 | 0.260 |
Why?
|
| Oligodendroglioma | 2 | 2018 | 274 | 0.250 |
Why?
|
| PrPSc Proteins | 1 | 2005 | 28 | 0.250 |
Why?
|
| Neuronal Plasticity | 4 | 2021 | 1446 | 0.250 |
Why?
|
| HIV Seropositivity | 1 | 2011 | 963 | 0.250 |
Why?
|
| Streptococcal Infections | 1 | 2010 | 618 | 0.250 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 2 | 2019 | 1433 | 0.250 |
Why?
|
| Nervous System Diseases | 4 | 2024 | 1660 | 0.250 |
Why?
|
| Developmental Disabilities | 1 | 2014 | 1518 | 0.240 |
Why?
|
| Annexins | 1 | 2025 | 40 | 0.240 |
Why?
|
| Hereditary Sensory and Autonomic Neuropathies | 3 | 2011 | 41 | 0.240 |
Why?
|
| Image Processing, Computer-Assisted | 15 | 2023 | 8940 | 0.240 |
Why?
|
| Aniline Compounds | 6 | 2019 | 1080 | 0.240 |
Why?
|
| TDP-43 Proteinopathies | 2 | 2023 | 40 | 0.240 |
Why?
|
| Creutzfeldt-Jakob Syndrome | 1 | 2005 | 92 | 0.240 |
Why?
|
| Ascites | 1 | 2006 | 336 | 0.240 |
Why?
|
| Cerebellar Ataxia | 2 | 2024 | 151 | 0.240 |
Why?
|
| Dura Mater | 1 | 2006 | 292 | 0.240 |
Why?
|
| Immunization, Passive | 1 | 2007 | 619 | 0.230 |
Why?
|
| Brain Chemistry | 7 | 2017 | 951 | 0.230 |
Why?
|
| Meningioma | 5 | 2022 | 1219 | 0.230 |
Why?
|
| Movement Disorders | 2 | 2007 | 462 | 0.230 |
Why?
|
| Gerstmann-Straussler-Scheinker Disease | 1 | 2024 | 10 | 0.230 |
Why?
|
| Nuclear Envelope | 1 | 2025 | 161 | 0.220 |
Why?
|
| Dominance, Ocular | 2 | 2021 | 30 | 0.220 |
Why?
|
| Antigens, Helminth | 2 | 2000 | 69 | 0.220 |
Why?
|
| Atrophy | 5 | 2022 | 1631 | 0.220 |
Why?
|
| Molecular Imaging | 2 | 2024 | 822 | 0.220 |
Why?
|
| Arteriolosclerosis | 1 | 2023 | 21 | 0.220 |
Why?
|
| Chromatography, Gel | 2 | 2021 | 634 | 0.210 |
Why?
|
| Formates | 2 | 2021 | 37 | 0.210 |
Why?
|
| Genes, Bacterial | 7 | 2001 | 1076 | 0.210 |
Why?
|
| Cerebrovascular Disorders | 5 | 2016 | 1478 | 0.210 |
Why?
|
| Lysosomal Storage Diseases | 3 | 2014 | 80 | 0.210 |
Why?
|
| Blood-Brain Barrier | 4 | 2019 | 1029 | 0.210 |
Why?
|
| Eosinophilia | 1 | 2007 | 554 | 0.210 |
Why?
|
| Microcirculation | 3 | 2015 | 1282 | 0.210 |
Why?
|
| Striatonigral Degeneration | 1 | 2022 | 13 | 0.210 |
Why?
|
| Immunohistochemistry | 24 | 2022 | 11063 | 0.210 |
Why?
|
| Disease Models, Animal | 26 | 2022 | 18330 | 0.210 |
Why?
|
| Olivopontocerebellar Atrophies | 1 | 2022 | 19 | 0.210 |
Why?
|
| Imaging, Three-Dimensional | 5 | 2024 | 4052 | 0.210 |
Why?
|
| Sialyltransferases | 3 | 1997 | 83 | 0.210 |
Why?
|
| Visual Cortex | 5 | 2021 | 1081 | 0.200 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 18 | 2017 | 3804 | 0.200 |
Why?
|
| Antigens, Surface | 4 | 2017 | 1617 | 0.200 |
Why?
|
| Ascomycota | 1 | 2003 | 81 | 0.200 |
Why?
|
| Consensus | 3 | 2019 | 3207 | 0.200 |
Why?
|
| Membrane Proteins | 12 | 2014 | 7868 | 0.200 |
Why?
|
| S100 Proteins | 2 | 2000 | 216 | 0.200 |
Why?
|
| Paresthesia | 2 | 2016 | 160 | 0.200 |
Why?
|
| RNA, Messenger | 11 | 2015 | 12793 | 0.200 |
Why?
|
| Adult | 57 | 2025 | 223317 | 0.200 |
Why?
|
| Phagocytes | 2 | 2003 | 292 | 0.200 |
Why?
|
| Dysarthria | 1 | 2022 | 56 | 0.200 |
Why?
|
| Temporal Arteries | 1 | 2003 | 155 | 0.190 |
Why?
|
| Receptor, Melanocortin, Type 1 | 1 | 2022 | 74 | 0.190 |
Why?
|
| Methylene Blue | 2 | 2012 | 156 | 0.190 |
Why?
|
| Vision, Ocular | 2 | 2017 | 457 | 0.190 |
Why?
|
| Genetic Predisposition to Disease | 14 | 2020 | 18063 | 0.190 |
Why?
|
| Molecular Epidemiology | 2 | 2018 | 473 | 0.190 |
Why?
|
| Meningeal Neoplasms | 3 | 2022 | 1253 | 0.190 |
Why?
|
| Histocytological Preparation Techniques | 1 | 2021 | 31 | 0.190 |
Why?
|
| Cells, Cultured | 21 | 2021 | 18989 | 0.190 |
Why?
|
| Fluorine Radioisotopes | 3 | 2019 | 405 | 0.190 |
Why?
|
| Central Nervous System Viral Diseases | 1 | 2021 | 39 | 0.190 |
Why?
|
| Telomerase | 2 | 2024 | 751 | 0.190 |
Why?
|
| Protein Multimerization | 4 | 2019 | 961 | 0.180 |
Why?
|
| Disease Progression | 15 | 2024 | 13646 | 0.180 |
Why?
|
| Dendrites | 3 | 2021 | 471 | 0.180 |
Why?
|
| Alternative Splicing | 3 | 2007 | 1103 | 0.180 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily B | 1 | 2021 | 85 | 0.180 |
Why?
|
| Biopsy | 10 | 2016 | 6777 | 0.180 |
Why?
|
| Cerebral Veins | 1 | 2002 | 157 | 0.180 |
Why?
|
| HEK293 Cells | 6 | 2021 | 4280 | 0.180 |
Why?
|
| Immunosuppressive Agents | 5 | 2020 | 4210 | 0.180 |
Why?
|
| Heat-Shock Proteins | 3 | 2006 | 792 | 0.180 |
Why?
|
| Benzhydryl Compounds | 1 | 2007 | 944 | 0.180 |
Why?
|
| Vision Disorders | 2 | 2019 | 1090 | 0.180 |
Why?
|
| Basal Ganglia Diseases | 1 | 2021 | 145 | 0.180 |
Why?
|
| Epitopes | 6 | 2017 | 2526 | 0.180 |
Why?
|
| Meninges | 4 | 2020 | 197 | 0.180 |
Why?
|
| Thiazoles | 6 | 2019 | 1530 | 0.170 |
Why?
|
| Biophysics | 1 | 2021 | 376 | 0.170 |
Why?
|
| Telepathology | 2 | 2012 | 77 | 0.170 |
Why?
|
| Genetic Variation | 8 | 2018 | 6611 | 0.170 |
Why?
|
| Calcium-Binding Proteins | 3 | 2015 | 1081 | 0.170 |
Why?
|
| Myocardium | 2 | 2016 | 4765 | 0.170 |
Why?
|
| Superoxide Dismutase | 2 | 2014 | 596 | 0.170 |
Why?
|
| Antigens, Differentiation | 2 | 2000 | 920 | 0.170 |
Why?
|
| Cerebrospinal Fluid | 3 | 2007 | 540 | 0.170 |
Why?
|
| Inclusion Bodies | 5 | 2017 | 277 | 0.170 |
Why?
|
| Serine C-Palmitoyltransferase | 3 | 2011 | 41 | 0.170 |
Why?
|
| Myocarditis | 1 | 2007 | 802 | 0.170 |
Why?
|
| Aging | 13 | 2023 | 8729 | 0.170 |
Why?
|
| Meningitis | 1 | 2021 | 219 | 0.170 |
Why?
|
| Microscopy | 4 | 2018 | 903 | 0.170 |
Why?
|
| Central Nervous System Neoplasms | 2 | 2019 | 928 | 0.170 |
Why?
|
| Chordoma | 1 | 2023 | 349 | 0.170 |
Why?
|
| Muscle Weakness | 2 | 2015 | 412 | 0.170 |
Why?
|
| Extracellular Fluid | 3 | 2019 | 165 | 0.170 |
Why?
|
| Bacterial Capsules | 3 | 1999 | 247 | 0.170 |
Why?
|
| Cell Size | 1 | 2021 | 624 | 0.170 |
Why?
|
| ATP-Binding Cassette Transporters | 3 | 2023 | 566 | 0.170 |
Why?
|
| Phenotype | 13 | 2024 | 16718 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 23 | 2019 | 22361 | 0.160 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 3 | 2020 | 2811 | 0.160 |
Why?
|
| Case-Control Studies | 17 | 2021 | 22254 | 0.160 |
Why?
|
| Limbic Encephalitis | 1 | 2019 | 36 | 0.160 |
Why?
|
| Siderosis | 1 | 2020 | 100 | 0.160 |
Why?
|
| Hypermedia | 1 | 1999 | 21 | 0.160 |
Why?
|
| Lipopolysaccharides | 6 | 2001 | 2217 | 0.160 |
Why?
|
| Solubility | 6 | 2012 | 1078 | 0.160 |
Why?
|
| Occipital Lobe | 2 | 2019 | 376 | 0.160 |
Why?
|
| HSP70 Heat-Shock Proteins | 2 | 2005 | 393 | 0.160 |
Why?
|
| Homozygote | 3 | 2020 | 1774 | 0.160 |
Why?
|
| Tomography, Optical Coherence | 3 | 2018 | 2954 | 0.160 |
Why?
|
| Central Nervous System Stimulants | 1 | 2007 | 1168 | 0.160 |
Why?
|
| Nissl Bodies | 1 | 2018 | 16 | 0.160 |
Why?
|
| Genetic Loci | 3 | 2019 | 2629 | 0.160 |
Why?
|
| Giant Cell Arteritis | 1 | 2003 | 307 | 0.160 |
Why?
|
| Calgranulin A | 4 | 2004 | 81 | 0.160 |
Why?
|
| Severity of Illness Index | 10 | 2021 | 15925 | 0.160 |
Why?
|
| Matrix Metalloproteinase 9 | 3 | 2015 | 633 | 0.160 |
Why?
|
| Myoclonus | 1 | 2019 | 107 | 0.160 |
Why?
|
| Calgranulin B | 4 | 2004 | 87 | 0.160 |
Why?
|
| Single-Cell Analysis | 6 | 2024 | 2538 | 0.160 |
Why?
|
| Drug Hypersensitivity | 1 | 2007 | 903 | 0.160 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2019 | 110 | 0.160 |
Why?
|
| Hydrogels | 2 | 2024 | 729 | 0.150 |
Why?
|
| Atlases as Topic | 2 | 2017 | 247 | 0.150 |
Why?
|
| Tuberous Sclerosis | 3 | 2009 | 1039 | 0.150 |
Why?
|
| Gait Disorders, Neurologic | 2 | 2014 | 243 | 0.150 |
Why?
|
| National Institute on Aging (U.S.) | 3 | 2015 | 40 | 0.150 |
Why?
|
| Microbiology | 1 | 1999 | 70 | 0.150 |
Why?
|
| Genes, Helminth | 2 | 2000 | 146 | 0.150 |
Why?
|
| Neoplasms, Neuroepithelial | 1 | 2018 | 43 | 0.150 |
Why?
|
| Mammals | 2 | 2021 | 1135 | 0.150 |
Why?
|
| Aortic Aneurysm | 1 | 2003 | 649 | 0.150 |
Why?
|
| Genotype | 15 | 2020 | 13035 | 0.150 |
Why?
|
| gamma-Aminobutyric Acid | 4 | 1992 | 1139 | 0.150 |
Why?
|
| Sterol O-Acyltransferase | 2 | 2010 | 28 | 0.150 |
Why?
|
| Up-Regulation | 9 | 2019 | 4143 | 0.150 |
Why?
|
| Peripheral Nerves | 2 | 2021 | 490 | 0.150 |
Why?
|
| Viruses | 1 | 2021 | 371 | 0.140 |
Why?
|
| Genome-Wide Association Study | 9 | 2022 | 12790 | 0.140 |
Why?
|
| Metagenome | 1 | 2021 | 464 | 0.140 |
Why?
|
| Apolipoproteins E | 8 | 2014 | 1459 | 0.140 |
Why?
|
| Encephalitis, Tick-Borne | 1 | 2018 | 45 | 0.140 |
Why?
|
| Mycoplasma hominis | 1 | 1997 | 10 | 0.140 |
Why?
|
| Perceptual Disorders | 1 | 2019 | 199 | 0.140 |
Why?
|
| Encephalitis Viruses, Tick-Borne | 1 | 2018 | 48 | 0.140 |
Why?
|
| Chaperonin 60 | 1 | 1997 | 97 | 0.140 |
Why?
|
| Endothelium | 1 | 2000 | 768 | 0.140 |
Why?
|
| Ischemic Attack, Transient | 2 | 2019 | 874 | 0.140 |
Why?
|
| Amyloidosis | 3 | 2016 | 876 | 0.140 |
Why?
|
| Cytoskeletal Proteins | 4 | 2017 | 1326 | 0.140 |
Why?
|
| Phospholipase C gamma | 1 | 2017 | 130 | 0.140 |
Why?
|
| Membrane Glycoproteins | 4 | 2017 | 3702 | 0.140 |
Why?
|
| Gene Expression | 6 | 2017 | 7587 | 0.140 |
Why?
|
| Pathology, Clinical | 2 | 2012 | 374 | 0.140 |
Why?
|
| Radiography | 7 | 2016 | 6975 | 0.140 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2019 | 409 | 0.140 |
Why?
|
| Pseudomonas aeruginosa | 2 | 1997 | 1277 | 0.140 |
Why?
|
| Enterobacteriaceae | 1 | 2018 | 161 | 0.140 |
Why?
|
| RNA Polymerase II | 1 | 2021 | 549 | 0.140 |
Why?
|
| Molecular Chaperones | 2 | 2005 | 760 | 0.140 |
Why?
|
| Mycoplasma Infections | 1 | 1997 | 120 | 0.140 |
Why?
|
| Inflammation Mediators | 4 | 2018 | 1889 | 0.140 |
Why?
|
| Species Specificity | 6 | 2021 | 2412 | 0.140 |
Why?
|
| Cerebellar Diseases | 1 | 2019 | 227 | 0.130 |
Why?
|
| Specimen Handling | 1 | 2021 | 706 | 0.130 |
Why?
|
| Sequence Analysis, DNA | 6 | 2018 | 4780 | 0.130 |
Why?
|
| Phenylalanine-tRNA Ligase | 1 | 2016 | 15 | 0.130 |
Why?
|
| Olfactory Pathways | 1 | 2017 | 131 | 0.130 |
Why?
|
| Neostriatum | 1 | 2017 | 231 | 0.130 |
Why?
|
| Gene Dosage | 5 | 2019 | 1211 | 0.130 |
Why?
|
| Stroke | 7 | 2013 | 9746 | 0.130 |
Why?
|
| Pyridines | 3 | 2024 | 2890 | 0.130 |
Why?
|
| Heterozygote | 5 | 2016 | 2794 | 0.130 |
Why?
|
| Reagent Strips | 1 | 1996 | 40 | 0.130 |
Why?
|
| Enterobacteriaceae Infections | 1 | 2018 | 190 | 0.130 |
Why?
|
| beta-Lactamases | 1 | 2018 | 307 | 0.130 |
Why?
|
| Nerve Degeneration | 2 | 2012 | 748 | 0.130 |
Why?
|
| RNA Splicing | 1 | 2000 | 903 | 0.130 |
Why?
|
| Paraplegia | 1 | 2016 | 161 | 0.130 |
Why?
|
| Erythrocyte Count | 1 | 1996 | 157 | 0.130 |
Why?
|
| MELAS Syndrome | 1 | 2016 | 55 | 0.130 |
Why?
|
| Molecular Sequence Data | 14 | 2002 | 17608 | 0.130 |
Why?
|
| Amyloidogenic Proteins | 1 | 2016 | 151 | 0.130 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2005 | 1107 | 0.130 |
Why?
|
| N-Acetylneuraminic Acid | 1 | 1996 | 174 | 0.130 |
Why?
|
| Escherichia coli O157 | 4 | 1999 | 53 | 0.130 |
Why?
|
| Oncogenes | 2 | 2018 | 1232 | 0.130 |
Why?
|
| Nerve Fibers, Myelinated | 2 | 2019 | 951 | 0.130 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2019 | 705 | 0.130 |
Why?
|
| Blood Vessels | 3 | 2024 | 1110 | 0.120 |
Why?
|
| Epilepsies, Myoclonic | 1 | 2016 | 83 | 0.120 |
Why?
|
| Neuroblastoma | 1 | 2023 | 1266 | 0.120 |
Why?
|
| Cell Survival | 3 | 2021 | 5750 | 0.120 |
Why?
|
| Immunoblotting | 7 | 2016 | 1647 | 0.120 |
Why?
|
| Receptors, Notch | 2 | 2011 | 751 | 0.120 |
Why?
|
| Point Mutation | 3 | 2016 | 1591 | 0.120 |
Why?
|
| Zebrafish | 2 | 2025 | 3036 | 0.120 |
Why?
|
| Smell | 1 | 2017 | 259 | 0.120 |
Why?
|
| Tissue Donors | 2 | 2024 | 2387 | 0.120 |
Why?
|
| Serotyping | 5 | 2000 | 331 | 0.120 |
Why?
|
| Ubiquitin | 2 | 2012 | 842 | 0.120 |
Why?
|
| Aspergillosis | 3 | 2002 | 241 | 0.120 |
Why?
|
| Tissue Preservation | 1 | 2015 | 170 | 0.120 |
Why?
|
| Electron Transport Complex I | 1 | 2016 | 152 | 0.120 |
Why?
|
| Vasoconstriction | 2 | 2016 | 591 | 0.120 |
Why?
|
| N-Acylneuraminate Cytidylyltransferase | 1 | 1994 | 7 | 0.120 |
Why?
|
| Knowledge | 1 | 2016 | 178 | 0.120 |
Why?
|
| Exons | 4 | 2022 | 2391 | 0.120 |
Why?
|
| Thrombotic Microangiopathies | 1 | 2016 | 124 | 0.120 |
Why?
|
| Sequence Analysis, RNA | 3 | 2018 | 2040 | 0.120 |
Why?
|
| Choroid Plexus | 1 | 2018 | 249 | 0.120 |
Why?
|
| Image Interpretation, Computer-Assisted | 3 | 2013 | 3370 | 0.120 |
Why?
|
| Visual Pathways | 2 | 2017 | 554 | 0.120 |
Why?
|
| G(M2) Ganglioside | 1 | 2014 | 14 | 0.120 |
Why?
|
| Hemosiderosis | 1 | 2015 | 66 | 0.120 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2019 | 582 | 0.120 |
Why?
|
| Polymorphism, Single Nucleotide | 10 | 2021 | 16036 | 0.120 |
Why?
|
| Base Sequence | 10 | 2002 | 12414 | 0.120 |
Why?
|
| Brain Infarction | 1 | 2016 | 285 | 0.120 |
Why?
|
| Tomography, Emission-Computed | 4 | 2002 | 1007 | 0.120 |
Why?
|
| Carrier State | 1 | 2018 | 529 | 0.120 |
Why?
|
| Family Health | 2 | 2017 | 1254 | 0.120 |
Why?
|
| Huntington Disease | 2 | 2012 | 1147 | 0.120 |
Why?
|
| Ion Channels | 3 | 2018 | 1043 | 0.120 |
Why?
|
| Caspases | 2 | 2008 | 881 | 0.110 |
Why?
|
| Anterior Thalamic Nuclei | 1 | 2014 | 27 | 0.110 |
Why?
|
| Shoes | 1 | 2014 | 91 | 0.110 |
Why?
|
| Receptors, Immunologic | 2 | 2017 | 1418 | 0.110 |
Why?
|
| Lipoproteins | 2 | 2001 | 871 | 0.110 |
Why?
|
| Oligodendroglia | 1 | 2018 | 539 | 0.110 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2017 | 2902 | 0.110 |
Why?
|
| Microscopy, Confocal | 4 | 2015 | 1969 | 0.110 |
Why?
|
| Meningitis, Bacterial | 1 | 1996 | 222 | 0.110 |
Why?
|
| Arterioles | 3 | 2011 | 252 | 0.110 |
Why?
|
| Crystallins | 1 | 1993 | 75 | 0.110 |
Why?
|
| Essential Tremor | 1 | 2016 | 160 | 0.110 |
Why?
|
| Proteomics | 3 | 2023 | 3913 | 0.110 |
Why?
|
| Multigene Family | 2 | 2011 | 1081 | 0.110 |
Why?
|
| Accidental Falls | 1 | 2022 | 1079 | 0.110 |
Why?
|
| Racemases and Epimerases | 1 | 1994 | 113 | 0.110 |
Why?
|
| Antigenic Variation | 1 | 1994 | 117 | 0.110 |
Why?
|
| Rats | 18 | 2018 | 23713 | 0.110 |
Why?
|
| Image Enhancement | 3 | 2013 | 2867 | 0.110 |
Why?
|
| Oxidative Stress | 4 | 2012 | 3139 | 0.110 |
Why?
|
| Plasmapheresis | 1 | 2014 | 205 | 0.110 |
Why?
|
| Axons | 3 | 2019 | 1675 | 0.110 |
Why?
|
| Cohort Studies | 15 | 2021 | 41718 | 0.110 |
Why?
|
| Gene Expression Regulation | 8 | 2018 | 11923 | 0.110 |
Why?
|
| Polysaccharides, Bacterial | 2 | 1994 | 582 | 0.110 |
Why?
|
| Neocortex | 4 | 2017 | 414 | 0.110 |
Why?
|
| Hallucinations | 1 | 2016 | 373 | 0.110 |
Why?
|
| Hematologic Tests | 1 | 2014 | 239 | 0.110 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2019 | 1493 | 0.110 |
Why?
|
| Protein Isoforms | 6 | 2018 | 1716 | 0.110 |
Why?
|
| Genetic Association Studies | 3 | 2024 | 2744 | 0.110 |
Why?
|
| Eye | 1 | 2017 | 711 | 0.100 |
Why?
|
| Pancreatitis, Alcoholic | 1 | 2012 | 28 | 0.100 |
Why?
|
| Demyelinating Diseases | 1 | 2015 | 354 | 0.100 |
Why?
|
| Immunity | 1 | 2019 | 1002 | 0.100 |
Why?
|
| Cell Line | 8 | 2020 | 15567 | 0.100 |
Why?
|
| Amino Acid Sequence | 10 | 2017 | 13411 | 0.100 |
Why?
|
| Trypsinogen | 1 | 2012 | 84 | 0.100 |
Why?
|
| Supranuclear Palsy, Progressive | 2 | 2017 | 82 | 0.100 |
Why?
|
| Glial Fibrillary Acidic Protein | 5 | 2020 | 564 | 0.100 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 5 | 2016 | 1729 | 0.100 |
Why?
|
| Quantitative Trait Loci | 2 | 2018 | 2131 | 0.100 |
Why?
|
| Peptides | 3 | 2023 | 4348 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2015 | 640 | 0.100 |
Why?
|
| Intranuclear Inclusion Bodies | 2 | 2013 | 34 | 0.100 |
Why?
|
| Optic Nerve Diseases | 1 | 2016 | 342 | 0.100 |
Why?
|
| Wakefulness | 1 | 2019 | 1282 | 0.100 |
Why?
|
| Neurites | 2 | 2015 | 389 | 0.100 |
Why?
|
| Venous Thrombosis | 1 | 2002 | 1321 | 0.100 |
Why?
|
| Protein Structure, Quaternary | 3 | 2012 | 424 | 0.100 |
Why?
|
| Amnesia | 1 | 2014 | 257 | 0.100 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2014 | 253 | 0.100 |
Why?
|
| Blotting, Western | 8 | 2017 | 5022 | 0.100 |
Why?
|
| Comorbidity | 2 | 2025 | 10582 | 0.100 |
Why?
|
| Homeodomain Proteins | 1 | 2021 | 2429 | 0.100 |
Why?
|
| Neoplasm Metastasis | 2 | 2020 | 4892 | 0.100 |
Why?
|
| Cytokines | 2 | 2018 | 7446 | 0.100 |
Why?
|
| Amyloid Precursor Protein Secretases | 4 | 2010 | 616 | 0.100 |
Why?
|
| Trypsin | 1 | 2012 | 490 | 0.100 |
Why?
|
| Prefrontal Cortex | 2 | 2022 | 2224 | 0.100 |
Why?
|
| Claudins | 1 | 2012 | 116 | 0.100 |
Why?
|
| Neoplastic Stem Cells | 2 | 2017 | 1349 | 0.100 |
Why?
|
| Sensory Deprivation | 1 | 2012 | 109 | 0.100 |
Why?
|
| CHO Cells | 7 | 2018 | 1376 | 0.100 |
Why?
|
| Retrospective Studies | 20 | 2024 | 81659 | 0.100 |
Why?
|
| Melanoma | 2 | 2022 | 5702 | 0.100 |
Why?
|
| MicroRNAs | 2 | 2020 | 3792 | 0.100 |
Why?
|
| Diagnostic Imaging | 4 | 2012 | 3530 | 0.100 |
Why?
|
| Sphingolipids | 2 | 2011 | 177 | 0.100 |
Why?
|
| Coloring Agents | 2 | 2012 | 565 | 0.090 |
Why?
|
| Receptor, EphA1 | 1 | 2011 | 20 | 0.090 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2021 | 2800 | 0.090 |
Why?
|
| Neural Pathways | 2 | 2021 | 3078 | 0.090 |
Why?
|
| Melanins | 2 | 2024 | 291 | 0.090 |
Why?
|
| Wechsler Scales | 1 | 2011 | 256 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 9 | 2012 | 6067 | 0.090 |
Why?
|
| Sick Role | 1 | 2011 | 229 | 0.090 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 2 | 2011 | 281 | 0.090 |
Why?
|
| Insulysin | 3 | 2011 | 49 | 0.090 |
Why?
|
| Neuroglia | 3 | 2023 | 960 | 0.090 |
Why?
|
| Surgical Wound Infection | 2 | 2018 | 1547 | 0.090 |
Why?
|
| Tumor Microenvironment | 3 | 2022 | 3944 | 0.090 |
Why?
|
| Apolipoprotein E3 | 3 | 2020 | 105 | 0.090 |
Why?
|
| Back Pain | 1 | 2015 | 547 | 0.090 |
Why?
|
| Cricetulus | 5 | 2018 | 810 | 0.090 |
Why?
|
| Walking | 2 | 2016 | 1201 | 0.090 |
Why?
|
| Lung Diseases, Fungal | 2 | 2002 | 123 | 0.090 |
Why?
|
| Anti-Inflammatory Agents | 3 | 2014 | 1804 | 0.090 |
Why?
|
| Haplotypes | 4 | 2024 | 2722 | 0.090 |
Why?
|
| Tomography | 1 | 2013 | 443 | 0.090 |
Why?
|
| Detergents | 4 | 2006 | 235 | 0.090 |
Why?
|
| Cricetinae | 8 | 2010 | 2415 | 0.090 |
Why?
|
| Neurotoxins | 1 | 2011 | 240 | 0.090 |
Why?
|
| Cerebral Angiography | 1 | 2016 | 1263 | 0.090 |
Why?
|
| Subtraction Technique | 1 | 2013 | 515 | 0.090 |
Why?
|
| Alkenes | 3 | 2009 | 54 | 0.090 |
Why?
|
| Streptococcus anginosus | 1 | 2010 | 25 | 0.090 |
Why?
|
| Ligases | 2 | 2002 | 330 | 0.090 |
Why?
|
| Cloning, Molecular | 5 | 1997 | 4167 | 0.090 |
Why?
|
| Statistics as Topic | 3 | 2012 | 2350 | 0.090 |
Why?
|
| Bacterial Toxins | 4 | 1999 | 922 | 0.090 |
Why?
|
| Receptors, GABA | 2 | 2022 | 312 | 0.090 |
Why?
|
| Microfilament Proteins | 3 | 2015 | 1130 | 0.090 |
Why?
|
| Rats, Wistar | 4 | 2018 | 1885 | 0.090 |
Why?
|
| Mitochondrial Proteins | 1 | 2016 | 980 | 0.090 |
Why?
|
| Sulfonic Acids | 1 | 2010 | 103 | 0.090 |
Why?
|
| Tissue Engineering | 1 | 2020 | 1861 | 0.090 |
Why?
|
| Alleles | 4 | 2020 | 6893 | 0.090 |
Why?
|
| Neuroprotective Agents | 1 | 2017 | 956 | 0.090 |
Why?
|
| Phagocytosis | 5 | 2017 | 1526 | 0.090 |
Why?
|
| Combined Modality Therapy | 6 | 2016 | 8535 | 0.080 |
Why?
|
| Reproducibility of Results | 10 | 2021 | 20169 | 0.080 |
Why?
|
| Transcription, Genetic | 3 | 2004 | 7611 | 0.080 |
Why?
|
| Lipids | 2 | 2019 | 3322 | 0.080 |
Why?
|
| Hyperoxaluria | 1 | 1989 | 33 | 0.080 |
Why?
|
| Algorithms | 5 | 2019 | 14098 | 0.080 |
Why?
|
| Hyperoxaluria, Primary | 1 | 1989 | 25 | 0.080 |
Why?
|
| Personality Assessment | 1 | 2011 | 646 | 0.080 |
Why?
|
| Phosphoproteins | 2 | 2017 | 2448 | 0.080 |
Why?
|
| Sphingosine | 1 | 2011 | 306 | 0.080 |
Why?
|
| Endopeptidases | 2 | 2004 | 762 | 0.080 |
Why?
|
| Purines | 1 | 2013 | 614 | 0.080 |
Why?
|
| Diseases in Twins | 2 | 2002 | 447 | 0.080 |
Why?
|
| Epistaxis | 1 | 2010 | 117 | 0.080 |
Why?
|
| Transaminases | 1 | 2010 | 198 | 0.080 |
Why?
|
| Recovery of Function | 2 | 2016 | 2978 | 0.080 |
Why?
|
| Societies, Medical | 2 | 2012 | 3964 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2010 | 310 | 0.080 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 1992 | 404 | 0.080 |
Why?
|
| Genes, Recessive | 1 | 2011 | 624 | 0.080 |
Why?
|
| Amygdala | 1 | 2017 | 1375 | 0.080 |
Why?
|
| Brain Diseases, Metabolic, Inborn | 1 | 2009 | 46 | 0.080 |
Why?
|
| Down Syndrome | 1 | 2017 | 916 | 0.080 |
Why?
|
| Proteins | 2 | 2014 | 6001 | 0.080 |
Why?
|
| Brain Injuries | 1 | 2021 | 2053 | 0.080 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2021 | 3667 | 0.080 |
Why?
|
| Age Factors | 8 | 2016 | 18401 | 0.080 |
Why?
|
| Acetates | 1 | 2010 | 314 | 0.080 |
Why?
|
| Contractile Proteins | 1 | 2010 | 240 | 0.080 |
Why?
|
| Fusobacterium nucleatum | 1 | 2010 | 176 | 0.080 |
Why?
|
| Blood Bactericidal Activity | 2 | 1999 | 124 | 0.080 |
Why?
|
| Postmortem Changes | 4 | 2013 | 119 | 0.080 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2018 | 8108 | 0.080 |
Why?
|
| Molecular Weight | 3 | 2018 | 2168 | 0.080 |
Why?
|
| Chlamydia Infections | 1 | 1992 | 365 | 0.080 |
Why?
|
| Water | 1 | 2015 | 1419 | 0.080 |
Why?
|
| Cost-Benefit Analysis | 2 | 2021 | 5537 | 0.080 |
Why?
|
| Blindness | 2 | 2017 | 585 | 0.080 |
Why?
|
| Stereotaxic Techniques | 2 | 2010 | 551 | 0.080 |
Why?
|
| Cerebrovascular Circulation | 2 | 2010 | 2672 | 0.080 |
Why?
|
| Clinical Protocols | 1 | 2014 | 1443 | 0.080 |
Why?
|
| Dissection | 2 | 2024 | 298 | 0.080 |
Why?
|
| Cervical Vertebrae | 2 | 2015 | 978 | 0.070 |
Why?
|
| Neurosurgical Procedures | 3 | 2024 | 2075 | 0.070 |
Why?
|
| Calcinosis | 1 | 2017 | 1481 | 0.070 |
Why?
|
| Cell Membrane | 2 | 2017 | 3642 | 0.070 |
Why?
|
| Child | 17 | 2023 | 80771 | 0.070 |
Why?
|
| Carrier Proteins | 2 | 2004 | 4925 | 0.070 |
Why?
|
| Dermatomyositis | 1 | 2011 | 259 | 0.070 |
Why?
|
| DNA Repeat Expansion | 2 | 2021 | 74 | 0.070 |
Why?
|
| Serine | 1 | 2011 | 828 | 0.070 |
Why?
|
| Practice Guidelines as Topic | 3 | 2015 | 7435 | 0.070 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2012 | 1319 | 0.070 |
Why?
|
| Cerebral Arteries | 4 | 2010 | 490 | 0.070 |
Why?
|
| Ataxia | 1 | 2010 | 307 | 0.070 |
Why?
|
| Adolescent | 18 | 2019 | 89046 | 0.070 |
Why?
|
| Meningitis, Meningococcal | 2 | 1998 | 43 | 0.070 |
Why?
|
| Migraine with Aura | 1 | 2010 | 203 | 0.070 |
Why?
|
| Threonine | 1 | 2008 | 272 | 0.070 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2011 | 663 | 0.070 |
Why?
|
| Endothelium, Vascular | 2 | 2015 | 4424 | 0.070 |
Why?
|
| Antigens, CD | 3 | 2011 | 4032 | 0.070 |
Why?
|
| Drainage | 1 | 2013 | 1183 | 0.070 |
Why?
|
| Connective Tissue | 1 | 2009 | 425 | 0.070 |
Why?
|
| Ultrasonography | 4 | 2012 | 6000 | 0.070 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2017 | 2745 | 0.070 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2011 | 453 | 0.070 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 2 | 2015 | 551 | 0.070 |
Why?
|
| Ischemia | 2 | 2013 | 1905 | 0.070 |
Why?
|
| Antifungal Agents | 2 | 2003 | 760 | 0.070 |
Why?
|
| Gene Frequency | 5 | 2017 | 3621 | 0.070 |
Why?
|
| Aphasia | 1 | 2009 | 193 | 0.070 |
Why?
|
| Foramen Ovale, Patent | 1 | 2010 | 210 | 0.070 |
Why?
|
| Subdural Effusion | 1 | 2006 | 19 | 0.070 |
Why?
|
| Long-Term Potentiation | 2 | 2019 | 289 | 0.070 |
Why?
|
| Child, Preschool | 12 | 2019 | 42606 | 0.070 |
Why?
|
| Dipeptides | 1 | 2009 | 386 | 0.070 |
Why?
|
| Remote Consultation | 1 | 2009 | 242 | 0.070 |
Why?
|
| Workflow | 2 | 2022 | 859 | 0.070 |
Why?
|
| Hemorrhage | 1 | 2019 | 3464 | 0.070 |
Why?
|
| Nephritis | 1 | 1987 | 146 | 0.070 |
Why?
|
| Electric Conductivity | 2 | 2021 | 405 | 0.070 |
Why?
|
| Alkaline Phosphatase | 1 | 2010 | 861 | 0.070 |
Why?
|
| Child Behavior Disorders | 1 | 2011 | 812 | 0.070 |
Why?
|
| Mice, Neurologic Mutants | 1 | 2006 | 107 | 0.070 |
Why?
|
| Lower Extremity | 1 | 2015 | 1217 | 0.070 |
Why?
|
| Protein Precursors | 1 | 2011 | 1134 | 0.070 |
Why?
|
| Predictive Value of Tests | 7 | 2021 | 15424 | 0.070 |
Why?
|
| Colombia | 2 | 2025 | 287 | 0.070 |
Why?
|
| Uric Acid | 1 | 2013 | 805 | 0.070 |
Why?
|
| DNA Primers | 5 | 2002 | 2827 | 0.070 |
Why?
|
| Proline | 1 | 2008 | 454 | 0.070 |
Why?
|
| Least-Squares Analysis | 2 | 2018 | 369 | 0.070 |
Why?
|
| Embolism | 1 | 2010 | 401 | 0.070 |
Why?
|
| Blood Cell Count | 1 | 2007 | 404 | 0.070 |
Why?
|
| Protein Binding | 5 | 2019 | 9327 | 0.070 |
Why?
|
| Pattern Recognition, Automated | 1 | 2012 | 987 | 0.070 |
Why?
|
| Plasmids | 4 | 1999 | 2268 | 0.070 |
Why?
|
| Genetic Heterogeneity | 2 | 2020 | 735 | 0.070 |
Why?
|
| Prealbumin | 1 | 2008 | 259 | 0.070 |
Why?
|
| Protein Subunits | 1 | 2009 | 940 | 0.070 |
Why?
|
| Chromatography, Liquid | 2 | 2023 | 996 | 0.070 |
Why?
|
| Basal Ganglia | 1 | 2009 | 549 | 0.060 |
Why?
|
| Cortical Spreading Depression | 1 | 2010 | 288 | 0.060 |
Why?
|
| Organ Culture Techniques | 2 | 2019 | 789 | 0.060 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2010 | 572 | 0.060 |
Why?
|
| Microscopy, Fluorescence | 2 | 2012 | 2628 | 0.060 |
Why?
|
| Escherichia coli | 4 | 2017 | 4209 | 0.060 |
Why?
|
| Electron Transport Complex IV | 1 | 2006 | 188 | 0.060 |
Why?
|
| Epilepsy | 3 | 2014 | 3317 | 0.060 |
Why?
|
| Sensitivity and Specificity | 8 | 2019 | 14672 | 0.060 |
Why?
|
| PrPC Proteins | 1 | 2005 | 35 | 0.060 |
Why?
|
| HSP40 Heat-Shock Proteins | 1 | 2005 | 85 | 0.060 |
Why?
|
| Pericardial Effusion | 1 | 2007 | 246 | 0.060 |
Why?
|
| Electroencephalography | 4 | 2010 | 6282 | 0.060 |
Why?
|
| Gene Expression Profiling | 6 | 2021 | 9532 | 0.060 |
Why?
|
| Blood Chemical Analysis | 1 | 2007 | 434 | 0.060 |
Why?
|
| Neoplasm Recurrence, Local | 5 | 2016 | 9410 | 0.060 |
Why?
|
| Prospective Studies | 10 | 2024 | 54886 | 0.060 |
Why?
|
| Isoflurane | 1 | 2008 | 383 | 0.060 |
Why?
|
| Blood Proteins | 3 | 2019 | 1190 | 0.060 |
Why?
|
| Protease Inhibitors | 1 | 2009 | 750 | 0.060 |
Why?
|
| Papilledema | 1 | 2006 | 130 | 0.060 |
Why?
|
| Reperfusion Injury | 2 | 2005 | 1043 | 0.060 |
Why?
|
| Mental Disorders | 2 | 2018 | 6873 | 0.060 |
Why?
|
| Measles | 1 | 2007 | 180 | 0.060 |
Why?
|
| Mitochondrial Diseases | 1 | 2009 | 344 | 0.060 |
Why?
|
| Ganglia, Spinal | 1 | 1988 | 529 | 0.060 |
Why?
|
| Linkage Disequilibrium | 3 | 2017 | 1996 | 0.060 |
Why?
|
| Substantia Nigra | 1 | 2007 | 346 | 0.060 |
Why?
|
| Down-Regulation | 2 | 2010 | 2931 | 0.060 |
Why?
|
| Immunity, Innate | 1 | 2017 | 3076 | 0.060 |
Why?
|
| Lamin Type B | 1 | 2025 | 28 | 0.060 |
Why?
|
| Clinical Trials as Topic | 2 | 2011 | 8048 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 4 | 2024 | 5796 | 0.060 |
Why?
|
| Steroids | 1 | 2010 | 937 | 0.060 |
Why?
|
| Indicators and Reagents | 1 | 1985 | 456 | 0.060 |
Why?
|
| Inflammation | 5 | 2020 | 10869 | 0.060 |
Why?
|
| Pulmonary Edema | 1 | 2007 | 408 | 0.060 |
Why?
|
| Phenanthrenes | 1 | 2005 | 65 | 0.060 |
Why?
|
| Capillaries | 3 | 2019 | 755 | 0.060 |
Why?
|
| Liver Transplantation | 1 | 1997 | 2416 | 0.060 |
Why?
|
| Young Adult | 12 | 2020 | 59980 | 0.060 |
Why?
|
| Photic Stimulation | 3 | 2019 | 1989 | 0.060 |
Why?
|
| Enzyme Inhibitors | 3 | 2010 | 3726 | 0.060 |
Why?
|
| Liver | 4 | 2010 | 7578 | 0.060 |
Why?
|
| Animals, Newborn | 4 | 2006 | 2677 | 0.060 |
Why?
|
| Genetic Testing | 3 | 2019 | 3591 | 0.060 |
Why?
|
| Kidney Failure, Chronic | 2 | 2004 | 2495 | 0.060 |
Why?
|
| Brain Mapping | 5 | 2023 | 6597 | 0.060 |
Why?
|
| Cardiomyopathies | 1 | 2016 | 2057 | 0.060 |
Why?
|
| Quinazolines | 1 | 2011 | 1369 | 0.060 |
Why?
|
| DNA Mutational Analysis | 6 | 2011 | 4114 | 0.060 |
Why?
|
| Liver Cirrhosis, Alcoholic | 1 | 2004 | 64 | 0.060 |
Why?
|
| Corpus Callosum | 1 | 2009 | 752 | 0.060 |
Why?
|
| Phosphatidylcholines | 1 | 1985 | 405 | 0.060 |
Why?
|
| Pulmonary Veins | 1 | 2010 | 761 | 0.060 |
Why?
|
| Porins | 2 | 2001 | 78 | 0.060 |
Why?
|
| Staphylococcus aureus | 1 | 1992 | 1429 | 0.060 |
Why?
|
| Neurofilament Proteins | 1 | 2006 | 335 | 0.060 |
Why?
|
| HIV | 1 | 2011 | 1591 | 0.060 |
Why?
|
| Granulomatous Disease, Chronic | 2 | 2002 | 175 | 0.060 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2013 | 6023 | 0.060 |
Why?
|
| Paecilomyces | 1 | 2003 | 3 | 0.060 |
Why?
|
| Recombinant Proteins | 6 | 2017 | 6507 | 0.060 |
Why?
|
| Protein Folding | 3 | 2014 | 869 | 0.050 |
Why?
|
| Lasers | 1 | 1988 | 951 | 0.050 |
Why?
|
| Lysophosphatidylcholines | 2 | 2017 | 77 | 0.050 |
Why?
|
| Recurrence | 5 | 2020 | 8504 | 0.050 |
Why?
|
| Corpus Striatum | 1 | 2010 | 1217 | 0.050 |
Why?
|
| Lipid Bilayers | 1 | 1985 | 377 | 0.050 |
Why?
|
| Anesthetics, Inhalation | 1 | 2008 | 573 | 0.050 |
Why?
|
| Receptors, Cell Surface | 4 | 2021 | 2815 | 0.050 |
Why?
|
| Cholinergic Agents | 1 | 2023 | 97 | 0.050 |
Why?
|
| Monoamine Oxidase | 1 | 2024 | 179 | 0.050 |
Why?
|
| DNA, Ribosomal Spacer | 1 | 2003 | 27 | 0.050 |
Why?
|
| T-Lymphocytes | 1 | 2021 | 10254 | 0.050 |
Why?
|
| Confusion | 1 | 2005 | 278 | 0.050 |
Why?
|
| Escherichia coli Infections | 4 | 1999 | 518 | 0.050 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2016 | 685 | 0.050 |
Why?
|
| Notochord | 1 | 2023 | 37 | 0.050 |
Why?
|
| Dermatomycoses | 1 | 2003 | 45 | 0.050 |
Why?
|
| Databases, Factual | 1 | 1999 | 8068 | 0.050 |
Why?
|
| Pyrimidinones | 1 | 1985 | 385 | 0.050 |
Why?
|
| Dementia, Multi-Infarct | 1 | 2002 | 10 | 0.050 |
Why?
|
| Exanthema | 1 | 2007 | 502 | 0.050 |
Why?
|
| Mice, Inbred C3H | 2 | 2017 | 915 | 0.050 |
Why?
|
| Mesencephalon | 2 | 2003 | 338 | 0.050 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2005 | 422 | 0.050 |
Why?
|
| Mice, Knockout | 7 | 2017 | 14476 | 0.050 |
Why?
|
| Genes, Dominant | 1 | 2005 | 855 | 0.050 |
Why?
|
| Follow-Up Studies | 8 | 2024 | 39317 | 0.050 |
Why?
|
| RNA, Viral | 1 | 2011 | 2867 | 0.050 |
Why?
|
| Olfactory Bulb | 1 | 1984 | 198 | 0.050 |
Why?
|
| Congo Red | 1 | 2002 | 49 | 0.050 |
Why?
|
| Mass Spectrometry | 3 | 2016 | 2201 | 0.050 |
Why?
|
| Advance Directives | 1 | 2004 | 249 | 0.050 |
Why?
|
| Protein Structure, Secondary | 2 | 2016 | 1211 | 0.050 |
Why?
|
| Immunoglobulin G | 5 | 2019 | 4560 | 0.050 |
Why?
|
| Brain Diseases | 2 | 2009 | 1551 | 0.050 |
Why?
|
| Geriatric Assessment | 1 | 2010 | 1422 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2006 | 2275 | 0.050 |
Why?
|
| Monocytes | 2 | 2014 | 2598 | 0.050 |
Why?
|
| Vertebral Artery | 1 | 2003 | 185 | 0.050 |
Why?
|
| Benzene Derivatives | 3 | 2009 | 51 | 0.050 |
Why?
|
| Blood Coagulation Tests | 1 | 2003 | 269 | 0.050 |
Why?
|
| DNA, Bacterial | 3 | 2000 | 1477 | 0.050 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2022 | 125 | 0.050 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2002 | 1900 | 0.050 |
Why?
|
| Hemolytic-Uremic Syndrome | 2 | 1999 | 104 | 0.050 |
Why?
|
| Benzene | 1 | 2002 | 106 | 0.050 |
Why?
|
| Open Reading Frames | 3 | 1998 | 818 | 0.050 |
Why?
|
| Infant | 7 | 2019 | 36485 | 0.050 |
Why?
|
| Chelating Agents | 2 | 2002 | 384 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2015 | 4572 | 0.050 |
Why?
|
| Spinal Cord Diseases | 1 | 2005 | 291 | 0.050 |
Why?
|
| Aorta, Abdominal | 1 | 2005 | 627 | 0.050 |
Why?
|
| DNA, Fungal | 1 | 2003 | 275 | 0.050 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2017 | 2472 | 0.050 |
Why?
|
| Fatty Acids | 2 | 2015 | 1806 | 0.050 |
Why?
|
| Seizures | 3 | 2010 | 2996 | 0.050 |
Why?
|
| Germany | 4 | 2011 | 882 | 0.050 |
Why?
|
| Anticoagulants | 2 | 2019 | 4854 | 0.050 |
Why?
|
| Hypotension | 1 | 2007 | 888 | 0.050 |
Why?
|
| Antigens, Human Platelet | 1 | 2001 | 41 | 0.050 |
Why?
|
| Antiphospholipid Syndrome | 1 | 2003 | 166 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 2 | 2023 | 1995 | 0.050 |
Why?
|
| Antibodies, Fungal | 1 | 2001 | 33 | 0.050 |
Why?
|
| Oculomotor Nerve | 1 | 2001 | 72 | 0.050 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 3 | 2006 | 5716 | 0.050 |
Why?
|
| Tritium | 2 | 2017 | 707 | 0.050 |
Why?
|
| Injections, Intraperitoneal | 2 | 2005 | 411 | 0.050 |
Why?
|
| Trematoda | 1 | 2000 | 3 | 0.050 |
Why?
|
| Carbohydrate Sequence | 2 | 2001 | 411 | 0.050 |
Why?
|
| Regression Analysis | 3 | 2016 | 6331 | 0.050 |
Why?
|
| Restriction Mapping | 3 | 1999 | 848 | 0.050 |
Why?
|
| Quadriplegia | 1 | 2023 | 227 | 0.050 |
Why?
|
| Legionella pneumophila | 1 | 2001 | 50 | 0.050 |
Why?
|
| Pulmonary Artery | 1 | 2010 | 1944 | 0.050 |
Why?
|
| Rare Diseases | 1 | 2006 | 630 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2015 | 3511 | 0.050 |
Why?
|
| Wiskott-Aldrich Syndrome | 1 | 2001 | 131 | 0.050 |
Why?
|
| Stilbenes | 3 | 2009 | 155 | 0.050 |
Why?
|
| Photography | 1 | 2024 | 536 | 0.050 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 3 | 1995 | 262 | 0.050 |
Why?
|
| Potassium Channels, Voltage-Gated | 1 | 2021 | 141 | 0.050 |
Why?
|
| Biomedical Research | 1 | 2016 | 3464 | 0.050 |
Why?
|
| Fluorodeoxyglucose F18 | 4 | 2007 | 2028 | 0.050 |
Why?
|
| RNA, Helminth | 1 | 2000 | 60 | 0.050 |
Why?
|
| Autoantibodies | 2 | 2022 | 2114 | 0.040 |
Why?
|
| Peptide Hydrolases | 1 | 2003 | 610 | 0.040 |
Why?
|
| Lymphoma | 1 | 2010 | 1896 | 0.040 |
Why?
|
| Meningococcal Vaccines | 1 | 2001 | 96 | 0.040 |
Why?
|
| Status Epilepticus | 1 | 2006 | 459 | 0.040 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2011 | 2055 | 0.040 |
Why?
|
| Candida | 1 | 2001 | 171 | 0.040 |
Why?
|
| Prognosis | 5 | 2024 | 29963 | 0.040 |
Why?
|
| Transfection | 5 | 2012 | 5753 | 0.040 |
Why?
|
| Neisseriaceae | 1 | 2000 | 6 | 0.040 |
Why?
|
| Odds Ratio | 3 | 2019 | 9660 | 0.040 |
Why?
|
| Methanol | 1 | 2001 | 91 | 0.040 |
Why?
|
| Ribonucleases | 1 | 2001 | 266 | 0.040 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2001 | 197 | 0.040 |
Why?
|
| Diarrhea | 4 | 1999 | 1319 | 0.040 |
Why?
|
| Models, Molecular | 3 | 2010 | 5388 | 0.040 |
Why?
|
| Databases, Genetic | 2 | 2011 | 1758 | 0.040 |
Why?
|
| T-Box Domain Proteins | 1 | 2023 | 471 | 0.040 |
Why?
|
| Cell Count | 3 | 2013 | 1825 | 0.040 |
Why?
|
| Nerve Net | 1 | 2012 | 2307 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2016 | 20741 | 0.040 |
Why?
|
| Abdominal Pain | 1 | 2006 | 1069 | 0.040 |
Why?
|
| Dilatation | 1 | 2021 | 311 | 0.040 |
Why?
|
| Thapsigargin | 1 | 2000 | 102 | 0.040 |
Why?
|
| Alcohol Dehydrogenase | 1 | 2000 | 113 | 0.040 |
Why?
|
| Egtazic Acid | 1 | 2000 | 165 | 0.040 |
Why?
|
| Acrylamide | 1 | 2020 | 59 | 0.040 |
Why?
|
| Microfluidic Analytical Techniques | 2 | 2017 | 789 | 0.040 |
Why?
|
| Foxes | 1 | 1999 | 10 | 0.040 |
Why?
|
| Fever | 1 | 2007 | 1605 | 0.040 |
Why?
|
| Influenza, Human | 1 | 2011 | 1543 | 0.040 |
Why?
|
| Urinary Incontinence | 1 | 2004 | 490 | 0.040 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2011 | 1481 | 0.040 |
Why?
|
| Twins, Monozygotic | 1 | 2002 | 471 | 0.040 |
Why?
|
| Matrix Metalloproteinase 13 | 1 | 2020 | 101 | 0.040 |
Why?
|
| Mitochondria | 2 | 2011 | 3678 | 0.040 |
Why?
|
| Echinococcosis, Hepatic | 1 | 1999 | 23 | 0.040 |
Why?
|
| RNA, Double-Stranded | 1 | 2021 | 292 | 0.040 |
Why?
|
| Aspergillus fumigatus | 1 | 2001 | 158 | 0.040 |
Why?
|
| Putamen | 1 | 2001 | 288 | 0.040 |
Why?
|
| Mycoses | 1 | 2003 | 386 | 0.040 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2003 | 541 | 0.040 |
Why?
|
| Risk Factors | 9 | 2019 | 74886 | 0.040 |
Why?
|
| Meningoencephalitis | 1 | 2020 | 82 | 0.040 |
Why?
|
| Ubiquitins | 1 | 2001 | 365 | 0.040 |
Why?
|
| Eye Enucleation | 2 | 2012 | 128 | 0.040 |
Why?
|
| Cadaver | 2 | 2015 | 1362 | 0.040 |
Why?
|
| Chromosome Mapping | 2 | 2014 | 4616 | 0.040 |
Why?
|
| Constipation | 1 | 2004 | 570 | 0.040 |
Why?
|
| DNA Copy Number Variations | 2 | 2020 | 2047 | 0.040 |
Why?
|
| Injections, Spinal | 1 | 2020 | 317 | 0.040 |
Why?
|
| Trinucleotide Repeats | 2 | 2013 | 257 | 0.040 |
Why?
|
| Time Factors | 8 | 2021 | 40154 | 0.040 |
Why?
|
| Nucleotides | 1 | 2022 | 454 | 0.040 |
Why?
|
| Peptides, Cyclic | 1 | 2001 | 390 | 0.040 |
Why?
|
| Bacterial Infections | 1 | 1987 | 1390 | 0.040 |
Why?
|
| Elastic Modulus | 1 | 2020 | 210 | 0.040 |
Why?
|
| Multivariate Analysis | 3 | 2018 | 12069 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2015 | 10748 | 0.040 |
Why?
|
| Tensile Strength | 1 | 2020 | 332 | 0.040 |
Why?
|
| Epitope Mapping | 2 | 2010 | 301 | 0.040 |
Why?
|
| Longitudinal Studies | 4 | 2018 | 14766 | 0.040 |
Why?
|
| Cell Lineage | 2 | 2019 | 2575 | 0.040 |
Why?
|
| Cross-Sectional Studies | 5 | 2023 | 26325 | 0.040 |
Why?
|
| Vasomotor System | 1 | 2019 | 208 | 0.040 |
Why?
|
| Myeloid Cells | 1 | 2024 | 837 | 0.040 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2023 | 637 | 0.040 |
Why?
|
| Gait | 1 | 2004 | 823 | 0.040 |
Why?
|
| Diffuse Cerebral Sclerosis of Schilder | 1 | 1998 | 17 | 0.040 |
Why?
|
| Intercellular Adhesion Molecule-1 | 3 | 2015 | 1132 | 0.040 |
Why?
|
| Drug Administration Schedule | 1 | 2007 | 4855 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2010 | 11872 | 0.040 |
Why?
|
| Genes, myc | 1 | 2020 | 391 | 0.040 |
Why?
|
| Receptors, LHRH | 1 | 1999 | 158 | 0.040 |
Why?
|
| Synaptic Potentials | 1 | 2018 | 43 | 0.040 |
Why?
|
| Tachycardia, Ventricular | 1 | 2007 | 1313 | 0.040 |
Why?
|
| Psychomotor Disorders | 1 | 2019 | 149 | 0.040 |
Why?
|
| Antibody Specificity | 2 | 1997 | 1062 | 0.040 |
Why?
|
| Biomimetic Materials | 1 | 2020 | 170 | 0.040 |
Why?
|
| Injections, Intraventricular | 1 | 2018 | 227 | 0.040 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2003 | 575 | 0.040 |
Why?
|
| Language Disorders | 1 | 2019 | 140 | 0.040 |
Why?
|
| Exudates and Transudates | 1 | 2019 | 175 | 0.040 |
Why?
|
| Organ Specificity | 2 | 2001 | 1966 | 0.040 |
Why?
|
| Capillary Permeability | 2 | 2019 | 772 | 0.040 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2015 | 505 | 0.040 |
Why?
|
| Deglutition Disorders | 1 | 2004 | 640 | 0.040 |
Why?
|
| Models, Biological | 2 | 2012 | 9464 | 0.040 |
Why?
|
| Brain Ischemia | 1 | 2011 | 3001 | 0.040 |
Why?
|
| Aorta, Thoracic | 1 | 2005 | 1110 | 0.040 |
Why?
|
| Signal Transduction | 5 | 2013 | 23621 | 0.040 |
Why?
|
| Action Potentials | 4 | 2018 | 1835 | 0.040 |
Why?
|
| Multilocus Sequence Typing | 1 | 2018 | 102 | 0.040 |
Why?
|
| Efficiency | 1 | 2021 | 479 | 0.040 |
Why?
|
| Collagenases | 1 | 1998 | 221 | 0.040 |
Why?
|
| Introns | 1 | 2000 | 965 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 1 | 2018 | 66 | 0.040 |
Why?
|
| Macrophage-1 Antigen | 1 | 1999 | 286 | 0.040 |
Why?
|
| Immunoglobulin A | 2 | 2001 | 992 | 0.040 |
Why?
|
| Tumor Escape | 1 | 2021 | 371 | 0.040 |
Why?
|
| Microscopy, Electron | 4 | 2008 | 2551 | 0.040 |
Why?
|
| Retinal Ganglion Cells | 3 | 1988 | 810 | 0.040 |
Why?
|
| Gene Library | 1 | 2000 | 1065 | 0.040 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2005 | 2270 | 0.040 |
Why?
|
| Analysis of Variance | 3 | 2013 | 6215 | 0.040 |
Why?
|
| Glutamic Acid | 2 | 2019 | 1182 | 0.040 |
Why?
|
| Memory Disorders | 2 | 2019 | 1193 | 0.040 |
Why?
|
| DNA, Ribosomal | 1 | 1999 | 300 | 0.040 |
Why?
|
| Glycolipids | 1 | 1998 | 203 | 0.040 |
Why?
|
| Vaccination | 1 | 2010 | 3434 | 0.040 |
Why?
|
| Lipid Metabolism | 2 | 2019 | 1895 | 0.040 |
Why?
|
| Isoantibodies | 1 | 2001 | 681 | 0.040 |
Why?
|
| Bacterial Typing Techniques | 1 | 2018 | 263 | 0.040 |
Why?
|
| Lectins, C-Type | 1 | 2021 | 591 | 0.040 |
Why?
|
| Apoptosis | 2 | 2008 | 9513 | 0.040 |
Why?
|
| Vital Capacity | 1 | 2020 | 996 | 0.040 |
Why?
|
| Unilamellar Liposomes | 1 | 2017 | 11 | 0.040 |
Why?
|
| Evaluation Studies as Topic | 2 | 1997 | 1623 | 0.040 |
Why?
|
| Angiomatosis | 1 | 1997 | 46 | 0.040 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 2 | 2015 | 692 | 0.030 |
Why?
|
| Cross-Linking Reagents | 1 | 2020 | 689 | 0.030 |
Why?
|
| Milk Proteins | 1 | 2017 | 161 | 0.030 |
Why?
|
| Integrins | 1 | 2001 | 840 | 0.030 |
Why?
|
| Fungal Proteins | 1 | 2001 | 901 | 0.030 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2003 | 843 | 0.030 |
Why?
|
| Antigens, Bacterial | 2 | 2001 | 1148 | 0.030 |
Why?
|
| Embryo, Mammalian | 3 | 2005 | 1676 | 0.030 |
Why?
|
| Transcription Factors | 3 | 2022 | 12158 | 0.030 |
Why?
|
| Liver Abscess | 1 | 1997 | 81 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2023 | 1197 | 0.030 |
Why?
|
| Calcium Channels | 1 | 2000 | 622 | 0.030 |
Why?
|
| Deoxyglucose | 1 | 1997 | 322 | 0.030 |
Why?
|
| Neisseria gonorrhoeae | 1 | 1999 | 249 | 0.030 |
Why?
|
| Radioligand Assay | 1 | 2017 | 365 | 0.030 |
Why?
|
| Cytoplasm | 1 | 2021 | 1504 | 0.030 |
Why?
|
| Immunoglobulin M | 2 | 2001 | 1527 | 0.030 |
Why?
|
| Materials Testing | 1 | 2020 | 870 | 0.030 |
Why?
|
| Protein Transport | 2 | 2012 | 1944 | 0.030 |
Why?
|
| Synovial Membrane | 1 | 1999 | 536 | 0.030 |
Why?
|
| Migraine Disorders | 1 | 2009 | 1712 | 0.030 |
Why?
|
| Pituitary Gland | 1 | 1999 | 635 | 0.030 |
Why?
|
| Octoxynol | 2 | 2006 | 76 | 0.030 |
Why?
|
| Reducing Agents | 1 | 2015 | 13 | 0.030 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2017 | 369 | 0.030 |
Why?
|
| DNA Transposable Elements | 1 | 2000 | 763 | 0.030 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2018 | 367 | 0.030 |
Why?
|
| Cell Proliferation | 3 | 2018 | 10455 | 0.030 |
Why?
|
| DNA, Helminth | 1 | 1995 | 36 | 0.030 |
Why?
|
| Fibrin | 1 | 2019 | 514 | 0.030 |
Why?
|
| Cost Savings | 1 | 2021 | 904 | 0.030 |
Why?
|
| Infant, Premature, Diseases | 1 | 2002 | 712 | 0.030 |
Why?
|
| Karnofsky Performance Status | 1 | 2016 | 162 | 0.030 |
Why?
|
| Gastritis | 1 | 1997 | 199 | 0.030 |
Why?
|
| Voluntary Health Agencies | 1 | 2015 | 38 | 0.030 |
Why?
|
| Electrophysiology | 2 | 1992 | 1263 | 0.030 |
Why?
|
| Complement C3 | 1 | 1997 | 434 | 0.030 |
Why?
|
| Protein Conformation | 3 | 2005 | 3948 | 0.030 |
Why?
|
| Kinetics | 4 | 2006 | 6287 | 0.030 |
Why?
|
| Shiga Toxins | 3 | 1999 | 39 | 0.030 |
Why?
|
| Cerebellar Neoplasms | 1 | 2000 | 590 | 0.030 |
Why?
|
| Salmonella typhimurium | 1 | 1998 | 348 | 0.030 |
Why?
|
| Pleura | 1 | 1997 | 245 | 0.030 |
Why?
|
| Cross Reactions | 1 | 1997 | 828 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2020 | 13491 | 0.030 |
Why?
|
| Anisotropy | 1 | 2019 | 1289 | 0.030 |
Why?
|
| Survival Rate | 3 | 2024 | 12823 | 0.030 |
Why?
|
| Surface Plasmon Resonance | 2 | 2009 | 268 | 0.030 |
Why?
|
| Neprilysin | 2 | 2011 | 487 | 0.030 |
Why?
|
| Mutation, Missense | 3 | 2011 | 2592 | 0.030 |
Why?
|
| Oligoribonucleotides, Antisense | 1 | 2014 | 14 | 0.030 |
Why?
|
| Aorta | 1 | 2003 | 2045 | 0.030 |
Why?
|
| Dependovirus | 1 | 2020 | 720 | 0.030 |
Why?
|
| Medulloblastoma | 1 | 2000 | 682 | 0.030 |
Why?
|
| Bacterial Proteins | 3 | 2001 | 3834 | 0.030 |
Why?
|
| Spinocerebellar Degenerations | 1 | 2014 | 44 | 0.030 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 1998 | 1057 | 0.030 |
Why?
|
| Genomics | 2 | 2022 | 5924 | 0.030 |
Why?
|
| Stress, Mechanical | 1 | 2020 | 1673 | 0.030 |
Why?
|
| Interleukin-5 | 1 | 2015 | 267 | 0.030 |
Why?
|
| Synaptophysin | 2 | 2006 | 138 | 0.030 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2021 | 1105 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2019 | 1837 | 0.030 |
Why?
|
| Registries | 1 | 2011 | 8351 | 0.030 |
Why?
|
| Molecular Targeted Therapy | 2 | 2017 | 2824 | 0.030 |
Why?
|
| Fetal Blood | 1 | 2001 | 1361 | 0.030 |
Why?
|
| Random Allocation | 1 | 2019 | 2394 | 0.030 |
Why?
|
| Echinococcosis, Pulmonary | 1 | 1994 | 7 | 0.030 |
Why?
|
| N-Acetylgalactosaminyltransferases | 1 | 2014 | 63 | 0.030 |
Why?
|
| Probability | 1 | 2020 | 2476 | 0.030 |
Why?
|
| Neurology | 1 | 2002 | 785 | 0.030 |
Why?
|
| Sheep Diseases | 1 | 1994 | 17 | 0.030 |
Why?
|
| Dosage Compensation, Genetic | 1 | 1995 | 209 | 0.030 |
Why?
|
| Melanocytes | 1 | 2018 | 509 | 0.030 |
Why?
|
| Rats, Inbred Lew | 1 | 1996 | 1168 | 0.030 |
Why?
|
| Echinococcosis | 1 | 1994 | 32 | 0.030 |
Why?
|
| Helicobacter pylori | 1 | 1997 | 380 | 0.030 |
Why?
|
| Cocaine | 1 | 2019 | 944 | 0.030 |
Why?
|
| Egypt | 1 | 1994 | 100 | 0.030 |
Why?
|
| Afghanistan | 1 | 1994 | 78 | 0.030 |
Why?
|
| Dermoscopy | 1 | 2014 | 73 | 0.030 |
Why?
|
| Helicobacter Infections | 1 | 1997 | 390 | 0.030 |
Why?
|
| Drosophila | 1 | 2021 | 1509 | 0.030 |
Why?
|
| Genome, Viral | 1 | 2018 | 673 | 0.030 |
Why?
|
| DNA, Complementary | 2 | 1995 | 1989 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2014 | 247 | 0.030 |
Why?
|
| Parkinsonian Disorders | 2 | 2011 | 285 | 0.030 |
Why?
|
| Serine Endopeptidases | 1 | 1999 | 1027 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2017 | 950 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2020 | 1505 | 0.030 |
Why?
|
| Sequence Homology | 1 | 1994 | 197 | 0.030 |
Why?
|
| Skull Base | 1 | 2016 | 294 | 0.030 |
Why?
|
| Acute Disease | 2 | 2019 | 7236 | 0.030 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2001 | 1063 | 0.030 |
Why?
|
| Equipment Design | 2 | 2012 | 3489 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2017 | 1337 | 0.030 |
Why?
|
| Autophagy | 1 | 2021 | 1347 | 0.030 |
Why?
|
| Binding, Competitive | 3 | 2002 | 1141 | 0.030 |
Why?
|
| Thrombocytopenia | 1 | 2001 | 1172 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2020 | 3618 | 0.030 |
Why?
|
| Alcoholism | 1 | 2004 | 1980 | 0.030 |
Why?
|
| Neoplasms | 1 | 2022 | 22350 | 0.030 |
Why?
|
| Tanzania | 1 | 2018 | 1406 | 0.030 |
Why?
|
| Xanthine | 1 | 2013 | 11 | 0.030 |
Why?
|
| Neuritis | 1 | 1993 | 35 | 0.030 |
Why?
|
| Neurofibromatosis 2 | 1 | 1997 | 387 | 0.030 |
Why?
|
| Mental Status Schedule | 1 | 2014 | 315 | 0.030 |
Why?
|
| DNA | 2 | 2022 | 7210 | 0.030 |
Why?
|
| Allergens | 1 | 2001 | 1436 | 0.030 |
Why?
|
| Kidney Transplantation | 2 | 2004 | 4268 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 3 | 1999 | 7469 | 0.030 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2018 | 667 | 0.030 |
Why?
|
| Administration, Oral | 2 | 2011 | 4026 | 0.030 |
Why?
|
| Cell Adhesion Molecules | 1 | 1999 | 1612 | 0.030 |
Why?
|
| Genes | 1 | 1997 | 1824 | 0.030 |
Why?
|
| In Situ Hybridization | 2 | 2012 | 1892 | 0.030 |
Why?
|
| Anatomy, Cross-Sectional | 1 | 2013 | 139 | 0.030 |
Why?
|
| Sural Nerve | 1 | 1993 | 105 | 0.030 |
Why?
|
| Retina | 3 | 1988 | 2659 | 0.030 |
Why?
|
| Reactive Oxygen Species | 2 | 2012 | 2144 | 0.030 |
Why?
|
| Antigens, Neoplasm | 1 | 2021 | 1997 | 0.030 |
Why?
|
| Transplantation, Homologous | 1 | 2001 | 4838 | 0.030 |
Why?
|
| Phylogeny | 2 | 2016 | 2840 | 0.030 |
Why?
|
| Contrast Media | 2 | 2019 | 5329 | 0.030 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2021 | 1814 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 2 | 1992 | 6226 | 0.030 |
Why?
|
| Cell Communication | 1 | 2000 | 1660 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2015 | 874 | 0.030 |
Why?
|
| Tetraethylammonium Compounds | 1 | 1992 | 31 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2014 | 534 | 0.030 |
Why?
|
| Disease Transmission, Infectious | 1 | 2018 | 560 | 0.030 |
Why?
|
| Adenoviridae | 1 | 2017 | 1092 | 0.030 |
Why?
|
| Tetraethylammonium | 1 | 1992 | 55 | 0.030 |
Why?
|
| Centrifugation, Density Gradient | 1 | 2012 | 297 | 0.030 |
Why?
|
| Synucleins | 2 | 2003 | 108 | 0.030 |
Why?
|
| Inosine | 1 | 2013 | 129 | 0.030 |
Why?
|
| Sex Factors | 3 | 2013 | 10622 | 0.030 |
Why?
|
| Consensus Development Conferences, NIH as Topic | 1 | 2012 | 29 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2000 | 1893 | 0.020 |
Why?
|
| Interneurons | 1 | 2017 | 592 | 0.020 |
Why?
|
| Escherichia coli Proteins | 1 | 1999 | 1055 | 0.020 |
Why?
|
| Diagnosis | 1 | 2013 | 157 | 0.020 |
Why?
|
| Depression, Chemical | 1 | 2011 | 186 | 0.020 |
Why?
|
| Neurologic Examination | 2 | 2010 | 913 | 0.020 |
Why?
|
| Organelle Size | 1 | 2011 | 6 | 0.020 |
Why?
|
| Cerebrovascular Trauma | 1 | 2011 | 21 | 0.020 |
Why?
|
| Sweden | 1 | 2015 | 1382 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2018 | 1366 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2007 | 3797 | 0.020 |
Why?
|
| Cognition | 2 | 2022 | 7059 | 0.020 |
Why?
|
| Lung | 1 | 2010 | 10076 | 0.020 |
Why?
|
| Killer Cells, Natural | 1 | 2021 | 2209 | 0.020 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2017 | 1142 | 0.020 |
Why?
|
| Cations | 1 | 1992 | 239 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2022 | 2979 | 0.020 |
Why?
|
| Pulse Therapy, Drug | 1 | 2011 | 37 | 0.020 |
Why?
|
| World Health Organization | 1 | 2017 | 1327 | 0.020 |
Why?
|
| Membrane Potentials | 2 | 1992 | 1085 | 0.020 |
Why?
|
| Intraoperative Period | 1 | 2012 | 512 | 0.020 |
Why?
|
| Antibodies, Bacterial | 3 | 1999 | 1477 | 0.020 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2016 | 1788 | 0.020 |
Why?
|
| Conserved Sequence | 1 | 1994 | 1160 | 0.020 |
Why?
|
| Data Display | 1 | 2012 | 174 | 0.020 |
Why?
|
| Sheep | 1 | 1994 | 1449 | 0.020 |
Why?
|
| Pituitary Gland, Posterior | 1 | 1991 | 42 | 0.020 |
Why?
|
| Sclerosis | 1 | 2011 | 211 | 0.020 |
Why?
|
| Oligonucleotide Probes | 1 | 1991 | 416 | 0.020 |
Why?
|
| Pluripotent Stem Cells | 1 | 2018 | 808 | 0.020 |
Why?
|
| Tetrodotoxin | 1 | 1992 | 243 | 0.020 |
Why?
|
| Electroretinography | 1 | 2013 | 524 | 0.020 |
Why?
|
| Visual Perception | 1 | 2019 | 1392 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2015 | 1604 | 0.020 |
Why?
|
| Chloride Channels | 1 | 1992 | 221 | 0.020 |
Why?
|
| Infection Control | 1 | 2018 | 984 | 0.020 |
Why?
|
| Stereoisomerism | 1 | 2011 | 612 | 0.020 |
Why?
|
| Abdomen | 1 | 1997 | 1138 | 0.020 |
Why?
|
| Medical Oncology | 1 | 2022 | 2341 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2020 | 3402 | 0.020 |
Why?
|
| Executive Function | 1 | 2019 | 1396 | 0.020 |
Why?
|
| Presenilin-2 | 2 | 2000 | 100 | 0.020 |
Why?
|
| Warfarin | 1 | 2019 | 1493 | 0.020 |
Why?
|
| Macromolecular Substances | 3 | 2003 | 1430 | 0.020 |
Why?
|
| Polynucleotides | 1 | 1990 | 27 | 0.020 |
Why?
|
| Internet | 2 | 2001 | 3114 | 0.020 |
Why?
|
| Thoracic Vertebrae | 1 | 2015 | 613 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2019 | 2493 | 0.020 |
Why?
|
| Voltage-Dependent Anion Channel 1 | 1 | 2010 | 35 | 0.020 |
Why?
|
| Presynaptic Terminals | 1 | 2012 | 299 | 0.020 |
Why?
|
| Crystallography, X-Ray | 2 | 2010 | 1947 | 0.020 |
Why?
|
| Oxalic Acid | 1 | 1989 | 20 | 0.020 |
Why?
|
| Blotting, Southern | 2 | 2001 | 775 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2022 | 4522 | 0.020 |
Why?
|
| Pain Perception | 1 | 2011 | 198 | 0.020 |
Why?
|
| Computer Communication Networks | 1 | 2012 | 292 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2015 | 998 | 0.020 |
Why?
|
| Genetic Markers | 2 | 2011 | 2602 | 0.020 |
Why?
|
| Radiation Injuries | 1 | 1997 | 1196 | 0.020 |
Why?
|
| Thermodynamics | 2 | 1995 | 581 | 0.020 |
Why?
|
| Syndrome | 1 | 2016 | 3271 | 0.020 |
Why?
|
| Urogenital System | 1 | 1989 | 88 | 0.020 |
Why?
|
| Fluorescence | 1 | 2012 | 751 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 1992 | 959 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 1994 | 2176 | 0.020 |
Why?
|
| Computational Biology | 1 | 2001 | 3567 | 0.020 |
Why?
|
| Macular Degeneration | 1 | 2017 | 1015 | 0.020 |
Why?
|
| Trans-Activators | 1 | 1999 | 2856 | 0.020 |
Why?
|
| Pedigree | 2 | 2015 | 4539 | 0.020 |
Why?
|
| Cerebral Amyloid Angiopathy, Familial | 1 | 2009 | 53 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2011 | 487 | 0.020 |
Why?
|
| Photomicrography | 1 | 2009 | 71 | 0.020 |
Why?
|
| Bacteremia | 1 | 1996 | 983 | 0.020 |
Why?
|
| Oxalates | 1 | 1989 | 99 | 0.020 |
Why?
|
| Fluorescent Dyes | 2 | 2009 | 1928 | 0.020 |
Why?
|
| Drug Therapy, Combination | 2 | 2011 | 6310 | 0.020 |
Why?
|
| COS Cells | 2 | 2002 | 1135 | 0.020 |
Why?
|
| Equipment Failure Analysis | 1 | 2012 | 832 | 0.020 |
Why?
|
| Cyclic N-Oxides | 1 | 2009 | 71 | 0.020 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2010 | 347 | 0.020 |
Why?
|
| Neural Stem Cells | 1 | 2016 | 895 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 1992 | 1697 | 0.020 |
Why?
|
| Receptors, Androgen | 1 | 1995 | 1089 | 0.020 |
Why?
|
| Alanine | 1 | 2011 | 613 | 0.020 |
Why?
|
| DNA Probes | 1 | 1990 | 541 | 0.020 |
Why?
|
| Injections, Intra-Articular | 1 | 2010 | 284 | 0.020 |
Why?
|
| Adrenal Cortex Hormones | 2 | 2011 | 1883 | 0.020 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2013 | 1442 | 0.020 |
Why?
|
| Dentate Gyrus | 1 | 2010 | 165 | 0.020 |
Why?
|
| Acetamides | 1 | 2010 | 259 | 0.020 |
Why?
|
| Immunologic Factors | 1 | 2018 | 1592 | 0.020 |
Why?
|
| Pregnancy | 3 | 2007 | 30238 | 0.020 |
Why?
|
| Immunoglobulin Variable Region | 1 | 2009 | 419 | 0.020 |
Why?
|
| Macrophages | 3 | 2017 | 5785 | 0.020 |
Why?
|
| Disease Management | 1 | 2019 | 2531 | 0.020 |
Why?
|
| Infertility, Male | 1 | 2011 | 396 | 0.020 |
Why?
|
| Gene Duplication | 1 | 2009 | 315 | 0.020 |
Why?
|
| Treatment Outcome | 5 | 2020 | 65295 | 0.020 |
Why?
|
| Pathology, Surgical | 1 | 2009 | 147 | 0.020 |
Why?
|
| Mecamylamine | 1 | 1988 | 27 | 0.020 |
Why?
|
| Peptide Library | 1 | 2009 | 351 | 0.020 |
Why?
|
| Tubocurarine | 1 | 1988 | 62 | 0.020 |
Why?
|
| Insulin | 1 | 2003 | 6602 | 0.020 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 1991 | 616 | 0.020 |
Why?
|
| Prednisone | 1 | 1993 | 1566 | 0.020 |
Why?
|
| Neuroaxonal Dystrophies | 1 | 2008 | 26 | 0.020 |
Why?
|
| Neuropsychological Tests | 2 | 2013 | 7121 | 0.020 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2019 | 2421 | 0.020 |
Why?
|
| Hereditary Central Nervous System Demyelinating Diseases | 1 | 2008 | 44 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2016 | 3552 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 1999 | 3610 | 0.020 |
Why?
|
| Sciatic Nerve | 1 | 2011 | 627 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2016 | 2457 | 0.020 |
Why?
|
| Polymorphism, Restriction Fragment Length | 2 | 1999 | 766 | 0.020 |
Why?
|
| Minocycline | 1 | 2009 | 170 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2011 | 13650 | 0.020 |
Why?
|
| Atropine | 1 | 1988 | 243 | 0.020 |
Why?
|
| Ubiquitination | 1 | 2012 | 1008 | 0.020 |
Why?
|
| Transgenes | 1 | 2011 | 1014 | 0.020 |
Why?
|
| Cell Differentiation | 3 | 2016 | 11657 | 0.020 |
Why?
|
| Histones | 1 | 2018 | 2597 | 0.020 |
Why?
|
| Smoking | 1 | 2004 | 9081 | 0.020 |
Why?
|
| Kidney Function Tests | 1 | 1989 | 683 | 0.020 |
Why?
|
| Galactosylgalactosylglucosylceramidase | 1 | 2006 | 4 | 0.020 |
Why?
|
| Glaucoma | 1 | 2017 | 1194 | 0.020 |
Why?
|
| Cell Death | 1 | 2012 | 1677 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2021 | 3797 | 0.020 |
Why?
|
| Amino Acid Substitution | 2 | 2003 | 1743 | 0.020 |
Why?
|
| Calcium | 1 | 2000 | 5792 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2016 | 2883 | 0.020 |
Why?
|
| Hamartoma | 1 | 2009 | 235 | 0.020 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2009 | 335 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2012 | 2063 | 0.020 |
Why?
|
| Europe | 1 | 1994 | 3432 | 0.020 |
Why?
|
| Immunotherapy | 1 | 2023 | 4745 | 0.020 |
Why?
|
| Laser-Doppler Flowmetry | 1 | 2007 | 236 | 0.020 |
Why?
|
| LDL-Receptor Related Proteins | 1 | 2007 | 118 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2015 | 1752 | 0.020 |
Why?
|
| Leukocyte Count | 2 | 2003 | 1606 | 0.020 |
Why?
|
| Brain Edema | 1 | 2011 | 601 | 0.020 |
Why?
|
| Microelectrodes | 1 | 1988 | 305 | 0.020 |
Why?
|
| Vibrissae | 1 | 2007 | 121 | 0.020 |
Why?
|
| Simvastatin | 1 | 2009 | 345 | 0.020 |
Why?
|
| Matrix Metalloproteinases | 1 | 2009 | 391 | 0.020 |
Why?
|
| Blood Coagulation | 1 | 2012 | 1163 | 0.020 |
Why?
|
| History, 20th Century | 1 | 2014 | 2765 | 0.020 |
Why?
|
| Skin Window Technique | 1 | 2006 | 22 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 2011 | 2227 | 0.020 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 1988 | 876 | 0.020 |
Why?
|
| Dementia, Vascular | 1 | 2007 | 126 | 0.020 |
Why?
|
| Glycosylation | 2 | 2001 | 1099 | 0.020 |
Why?
|
| Hyperemia | 1 | 2007 | 223 | 0.020 |
Why?
|
| Camptothecin | 1 | 2009 | 599 | 0.020 |
Why?
|
| Vision, Monocular | 1 | 2006 | 71 | 0.020 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2016 | 2058 | 0.020 |
Why?
|
| Hypercapnia | 1 | 2007 | 259 | 0.020 |
Why?
|
| Physical Stimulation | 1 | 2007 | 514 | 0.020 |
Why?
|
| Sepsis | 1 | 2000 | 2605 | 0.020 |
Why?
|
| Pancreas, Exocrine | 1 | 2005 | 48 | 0.020 |
Why?
|
| 3T3 Cells | 2 | 1999 | 1081 | 0.020 |
Why?
|
| Lumbar Vertebrae | 1 | 2015 | 1885 | 0.020 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2008 | 661 | 0.020 |
Why?
|
| Virulence | 2 | 1999 | 1294 | 0.020 |
Why?
|
| United States | 4 | 2015 | 72971 | 0.020 |
Why?
|
| Kidney Calculi | 1 | 1989 | 458 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2016 | 2952 | 0.020 |
Why?
|
| Geniculate Bodies | 1 | 2006 | 157 | 0.020 |
Why?
|
| Drug Resistance, Microbial | 2 | 1998 | 831 | 0.020 |
Why?
|
| Bacteria | 1 | 1996 | 2212 | 0.020 |
Why?
|
| Glycine | 1 | 1988 | 670 | 0.020 |
Why?
|
| Protease Nexins | 1 | 2004 | 39 | 0.020 |
Why?
|
| Cholesterol Esters | 1 | 2004 | 68 | 0.010 |
Why?
|
| Necrosis | 2 | 2001 | 1614 | 0.010 |
Why?
|
| Hospitals | 1 | 2018 | 3883 | 0.010 |
Why?
|
| Poly Adenosine Diphosphate Ribose | 1 | 2005 | 51 | 0.010 |
Why?
|
| Memory | 1 | 2014 | 2192 | 0.010 |
Why?
|
| Receptors, Nicotinic | 1 | 1988 | 494 | 0.010 |
Why?
|
| rho-Associated Kinases | 1 | 2006 | 290 | 0.010 |
Why?
|
| Delivery of Health Care | 1 | 2022 | 5363 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2011 | 2509 | 0.010 |
Why?
|
| Mathematics | 1 | 1985 | 696 | 0.010 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2003 | 1969 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 2010 | 2221 | 0.010 |
Why?
|
| Carnosine | 1 | 1984 | 6 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2015 | 4349 | 0.010 |
Why?
|
| Myelin Sheath | 1 | 2008 | 649 | 0.010 |
Why?
|
| Arthritis, Rheumatoid | 1 | 1999 | 3778 | 0.010 |
Why?
|
| Discriminant Analysis | 1 | 2004 | 222 | 0.010 |
Why?
|
| Fluoresceins | 1 | 1984 | 235 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 2016 | 3599 | 0.010 |
Why?
|
| Leucine | 1 | 2005 | 547 | 0.010 |
Why?
|
| Psychomotor Performance | 1 | 2011 | 1886 | 0.010 |
Why?
|
| Functional Laterality | 1 | 2010 | 2245 | 0.010 |
Why?
|
| Vasodilation | 1 | 2007 | 968 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2016 | 10092 | 0.010 |
Why?
|
| Amphotericin B | 1 | 2003 | 140 | 0.010 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2004 | 308 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2008 | 3587 | 0.010 |
Why?
|
| Optic Nerve | 1 | 2006 | 568 | 0.010 |
Why?
|
| Endothelial Cells | 1 | 2015 | 3582 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2019 | 17097 | 0.010 |
Why?
|
| Methionine | 1 | 2005 | 570 | 0.010 |
Why?
|
| Microsurgery | 1 | 1988 | 798 | 0.010 |
Why?
|
| Phenanthrolines | 1 | 2002 | 48 | 0.010 |
Why?
|
| RNA | 1 | 2012 | 2715 | 0.010 |
Why?
|
| Chemistry, Physical | 1 | 2002 | 153 | 0.010 |
Why?
|
| Linear Models | 1 | 2012 | 5875 | 0.010 |
Why?
|
| Patient Selection | 1 | 2014 | 4256 | 0.010 |
Why?
|
| Receptors, Collagen | 1 | 2001 | 25 | 0.010 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2004 | 415 | 0.010 |
Why?
|
| Blood Sedimentation | 1 | 2003 | 235 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2009 | 2668 | 0.010 |
Why?
|
| Adrenal Glands | 1 | 2004 | 557 | 0.010 |
Why?
|
| Microinjections | 2 | 1993 | 319 | 0.010 |
Why?
|
| Chemical Phenomena | 1 | 2002 | 486 | 0.010 |
Why?
|
| Integrin alpha2 | 1 | 2001 | 39 | 0.010 |
Why?
|
| Amino Acids | 1 | 1988 | 1712 | 0.010 |
Why?
|
| Echinocandins | 1 | 2001 | 54 | 0.010 |
Why?
|
| Transformation, Bacterial | 1 | 2001 | 79 | 0.010 |
Why?
|
| Chemical Fractionation | 1 | 2001 | 60 | 0.010 |
Why?
|
| Lipopeptides | 1 | 2001 | 71 | 0.010 |
Why?
|
| Reflex, Pupillary | 1 | 2001 | 63 | 0.010 |
Why?
|
| DNA Methylation | 1 | 2016 | 4426 | 0.010 |
Why?
|
| Putaminal Hemorrhage | 1 | 2001 | 5 | 0.010 |
Why?
|
| Craniotomy | 1 | 2006 | 736 | 0.010 |
Why?
|
| Carbon Radioisotopes | 1 | 2002 | 544 | 0.010 |
Why?
|
| Cholesterol | 1 | 2010 | 2905 | 0.010 |
Why?
|
| Cysteine Endopeptidases | 1 | 2004 | 542 | 0.010 |
Why?
|
| Immunity, Maternally-Acquired | 1 | 2001 | 112 | 0.010 |
Why?
|
| Antigens, Fungal | 1 | 2001 | 69 | 0.010 |
Why?
|
| Benzothiazoles | 1 | 2002 | 244 | 0.010 |
Why?
|
| Mutagenesis | 1 | 2005 | 1227 | 0.010 |
Why?
|
| Laser Therapy | 1 | 1988 | 1108 | 0.010 |
Why?
|
| Antigens, Plant | 1 | 2001 | 104 | 0.010 |
Why?
|
| Cytochalasin D | 1 | 2000 | 91 | 0.010 |
Why?
|
| Hydrolysis | 1 | 2002 | 645 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2012 | 5311 | 0.010 |
Why?
|
| Glycerophospholipids | 1 | 2000 | 39 | 0.010 |
Why?
|
| 3-Hydroxybutyric Acid | 1 | 2000 | 72 | 0.010 |
Why?
|
| Calcium Channels, N-Type | 1 | 2000 | 42 | 0.010 |
Why?
|
| Sulfonamides | 1 | 2010 | 1982 | 0.010 |
Why?
|
| Nuclear Family | 1 | 2001 | 311 | 0.010 |
Why?
|
| Freezing | 1 | 2001 | 310 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2006 | 2850 | 0.010 |
Why?
|
| Multienzyme Complexes | 1 | 2004 | 663 | 0.010 |
Why?
|
| Sphingomyelins | 1 | 2000 | 104 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2007 | 3760 | 0.010 |
Why?
|
| Acetyltransferases | 1 | 2001 | 230 | 0.010 |
Why?
|
| Renal Dialysis | 1 | 1989 | 1790 | 0.010 |
Why?
|
| Risk | 1 | 2012 | 9606 | 0.010 |
Why?
|
| O Antigens | 1 | 2001 | 196 | 0.010 |
Why?
|
| Gangliosides | 1 | 2000 | 132 | 0.010 |
Why?
|
| Sorbitol | 1 | 1999 | 61 | 0.010 |
Why?
|
| Glucose Tolerance Test | 1 | 2003 | 1181 | 0.010 |
Why?
|
| Neurotransmitter Agents | 1 | 2004 | 661 | 0.010 |
Why?
|
| Cytosol | 1 | 2003 | 885 | 0.010 |
Why?
|
| Dopamine | 1 | 2007 | 1581 | 0.010 |
Why?
|
| Glycogen Synthase Kinases | 1 | 1999 | 40 | 0.010 |
Why?
|
| Antibodies, Helminth | 1 | 1999 | 59 | 0.010 |
Why?
|
| Motor Neurons | 1 | 2005 | 869 | 0.010 |
Why?
|
| Abscess | 1 | 2003 | 606 | 0.010 |
Why?
|
| Culture Media | 1 | 2001 | 892 | 0.010 |
Why?
|
| Ion Transport | 1 | 2000 | 322 | 0.010 |
Why?
|
| Fermentation | 1 | 1999 | 143 | 0.010 |
Why?
|
| Phalloidine | 1 | 1999 | 21 | 0.010 |
Why?
|
| Random Amplified Polymorphic DNA Technique | 1 | 1999 | 20 | 0.010 |
Why?
|
| Crosses, Genetic | 1 | 2000 | 751 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2012 | 6260 | 0.010 |
Why?
|
| Shiga Toxin 1 | 1 | 1998 | 42 | 0.010 |
Why?
|
| Calcium Channels, L-Type | 1 | 2000 | 243 | 0.010 |
Why?
|
| Glucose Intolerance | 1 | 2003 | 579 | 0.010 |
Why?
|
| Protozoan Proteins | 1 | 2005 | 843 | 0.010 |
Why?
|
| Respiratory Burst | 1 | 1999 | 110 | 0.010 |
Why?
|
| Picrotoxin | 2 | 1988 | 61 | 0.010 |
Why?
|
| Synaptic Membranes | 1 | 1998 | 88 | 0.010 |
Why?
|
| Arginine | 1 | 2002 | 931 | 0.010 |
Why?
|
| Candida albicans | 1 | 2001 | 376 | 0.010 |
Why?
|
| Microvilli | 1 | 1999 | 235 | 0.010 |
Why?
|
| Acetylation | 1 | 2001 | 1055 | 0.010 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2001 | 502 | 0.010 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 1999 | 256 | 0.010 |
Why?
|
| Pseudopodia | 1 | 1999 | 167 | 0.010 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 1998 | 149 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2011 | 8732 | 0.010 |
Why?
|
| Dimerization | 1 | 1999 | 882 | 0.010 |
Why?
|
| Seroepidemiologic Studies | 1 | 1999 | 404 | 0.010 |
Why?
|
| Patch-Clamp Techniques | 1 | 2000 | 924 | 0.010 |
Why?
|
| Cyclophosphamide | 1 | 2004 | 2227 | 0.010 |
Why?
|
| Gallbladder | 1 | 1999 | 308 | 0.010 |
Why?
|
| Serologic Tests | 1 | 2000 | 382 | 0.010 |
Why?
|
| Transplantation, Autologous | 1 | 2003 | 2118 | 0.010 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1999 | 492 | 0.010 |
Why?
|
| Evoked Potentials | 1 | 1984 | 1050 | 0.010 |
Why?
|
| Artificial Intelligence | 1 | 2012 | 2666 | 0.010 |
Why?
|
| Zinc | 1 | 2002 | 675 | 0.010 |
Why?
|
| Behavior, Animal | 1 | 2005 | 1865 | 0.010 |
Why?
|
| Cysteine | 1 | 2002 | 896 | 0.010 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 1999 | 350 | 0.010 |
Why?
|
| Adenomatous Polyposis Coli | 1 | 1999 | 219 | 0.010 |
Why?
|
| E-Selectin | 1 | 1999 | 576 | 0.010 |
Why?
|
| Kidney | 2 | 1995 | 7063 | 0.010 |
Why?
|
| Megakaryocytes | 1 | 2001 | 557 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 2001 | 1750 | 0.010 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 1999 | 414 | 0.010 |
Why?
|
| Staphylococcal Protein A | 1 | 1996 | 39 | 0.010 |
Why?
|
| Calcium Channel Blockers | 1 | 2000 | 688 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2000 | 1677 | 0.010 |
Why?
|
| Phenylalanine | 1 | 1998 | 367 | 0.010 |
Why?
|
| Metalloendopeptidases | 1 | 1998 | 386 | 0.010 |
Why?
|
| Hemolysis | 1 | 1999 | 417 | 0.010 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 1996 | 122 | 0.010 |
Why?
|
| Clone Cells | 1 | 2000 | 1669 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 2002 | 3052 | 0.010 |
Why?
|
| Complement System Proteins | 1 | 1999 | 738 | 0.010 |
Why?
|
| Cell Division | 1 | 1984 | 4473 | 0.010 |
Why?
|
| Intracranial Pressure | 1 | 1998 | 323 | 0.010 |
Why?
|
| Anticonvulsants | 1 | 2006 | 1921 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2006 | 2887 | 0.010 |
Why?
|
| Receptor, Notch1 | 1 | 1999 | 518 | 0.010 |
Why?
|
| Brain Stem | 1 | 2001 | 858 | 0.010 |
Why?
|
| Phosphoglycerate Kinase | 1 | 1995 | 66 | 0.010 |
Why?
|
| Macaca mulatta | 2 | 1993 | 2345 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2005 | 3427 | 0.010 |
Why?
|
| Chemotaxis | 1 | 1999 | 598 | 0.010 |
Why?
|
| Gene Targeting | 1 | 1999 | 841 | 0.010 |
Why?
|
| Morphogenesis | 1 | 1999 | 746 | 0.010 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1999 | 792 | 0.010 |
Why?
|
| Haptens | 1 | 1995 | 163 | 0.010 |
Why?
|
| Terminology as Topic | 1 | 2002 | 1540 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2010 | 5794 | 0.010 |
Why?
|
| Radiography, Thoracic | 1 | 2002 | 1320 | 0.010 |
Why?
|
| Catalysis | 1 | 1996 | 766 | 0.010 |
Why?
|
| Learning | 1 | 2004 | 1754 | 0.010 |
Why?
|
| Binding Sites, Antibody | 1 | 1995 | 340 | 0.010 |
Why?
|
| Rabbits | 1 | 2001 | 4751 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2001 | 2721 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 1995 | 348 | 0.010 |
Why?
|
| Reference Values | 1 | 2001 | 4918 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2002 | 6106 | 0.010 |
Why?
|
| Cadherins | 1 | 1999 | 903 | 0.010 |
Why?
|
| Imidazoles | 1 | 2000 | 1169 | 0.010 |
Why?
|
| Infant, Newborn | 3 | 2002 | 26396 | 0.010 |
Why?
|
| Crystallization | 1 | 1995 | 518 | 0.010 |
Why?
|
| Thiophenes | 1 | 1998 | 570 | 0.010 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2009 | 3249 | 0.010 |
Why?
|
| beta Catenin | 1 | 1999 | 1048 | 0.010 |
Why?
|
| Salvage Therapy | 1 | 2000 | 1271 | 0.010 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 1995 | 446 | 0.010 |
Why?
|
| Intestine, Small | 1 | 1999 | 1217 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1995 | 1550 | 0.010 |
Why?
|
| Cerebellum | 1 | 2000 | 1521 | 0.010 |
Why?
|
| Cesarean Section | 1 | 2002 | 1419 | 0.010 |
Why?
|
| Lysosomes | 1 | 1998 | 937 | 0.010 |
Why?
|
| Methylation | 1 | 1995 | 1076 | 0.010 |
Why?
|
| Liver Cirrhosis | 1 | 2003 | 1959 | 0.010 |
Why?
|
| Incidence | 1 | 2011 | 21526 | 0.010 |
Why?
|
| HeLa Cells | 1 | 1999 | 3073 | 0.010 |
Why?
|
| Pia Mater | 1 | 1992 | 85 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 1999 | 1791 | 0.010 |
Why?
|
| Interviews as Topic | 1 | 1999 | 2741 | 0.010 |
Why?
|
| Macaca nemestrina | 1 | 1991 | 19 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 1992 | 697 | 0.010 |
Why?
|
| Actins | 1 | 1999 | 2059 | 0.010 |
Why?
|
| Bone Marrow | 1 | 2001 | 2926 | 0.010 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1991 | 221 | 0.010 |
Why?
|
| Chromosome Deletion | 1 | 1995 | 1384 | 0.010 |
Why?
|
| Autoimmune Diseases | 1 | 2003 | 2255 | 0.010 |
Why?
|
| Neurons, Afferent | 1 | 1993 | 498 | 0.010 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 1990 | 283 | 0.010 |
Why?
|
| Pituitary Neoplasms | 1 | 1999 | 1322 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2000 | 3684 | 0.010 |
Why?
|
| Immune Sera | 1 | 1990 | 605 | 0.010 |
Why?
|
| Hypertension | 1 | 2010 | 8615 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 1997 | 1405 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 1990 | 816 | 0.010 |
Why?
|
| Diagnostic Errors | 1 | 1997 | 1278 | 0.010 |
Why?
|
| Chromatography, Affinity | 1 | 1990 | 524 | 0.010 |
Why?
|
| Antibody Affinity | 1 | 1990 | 251 | 0.000 |
Why?
|
| Strychnine | 1 | 1988 | 34 | 0.000 |
Why?
|
| Neoadjuvant Therapy | 1 | 2000 | 2902 | 0.000 |
Why?
|
| Bicuculline | 1 | 1988 | 96 | 0.000 |
Why?
|
| Rural Population | 1 | 1999 | 2321 | 0.000 |
Why?
|
| Receptors, Amino Acid | 1 | 1988 | 30 | 0.000 |
Why?
|
| Blood Glucose | 1 | 2003 | 6421 | 0.000 |
Why?
|
| Taurine | 1 | 1988 | 91 | 0.000 |
Why?
|
| Neutrophils | 1 | 1999 | 3779 | 0.000 |
Why?
|
| Neoplasm Staging | 1 | 2000 | 11217 | 0.000 |
Why?
|
| Rats, Inbred Strains | 1 | 1986 | 2078 | 0.000 |
Why?
|
| Antigens | 1 | 1990 | 1442 | 0.000 |
Why?
|
| DNA Replication | 1 | 1991 | 1426 | 0.000 |
Why?
|
| Chronic Disease | 1 | 1997 | 9362 | 0.000 |
Why?
|